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Osteochondral tissue is a biphasic material comprised of articular cartilage integrated atop
subchondral bone. Damage to this tissue is highly problematic, owing to its intrinsic inability to
regenerate functional tissue in response to trauma or disease. Further, the function of the
tissue is largely conferred by its compartmentalized zonal microstructure and composition.
Current clinical treatments fail to regenerate new tissue that recapitulates this zonal structure.
Consequently, regenerated tissue often lacks long-term stability. To address this growing
problem, we propose the development of tissue engineered biomaterials that mimic the zonal
collagen orientation and composition of osteochondral tissue. First, a unidirectional freeze
casting platform was developed that facilitated the fabrication of highly-aligned porous
collagen scaffolds to serve as the superficial zone of the multidirectional scaffold.
Subsequently, a novel lyophilization bonding process, which seamlessly bonds scaffolds with
different orientations and compositions together, forming a monolithic multidirectional
collagen-based scaffolds that mimicked the structure and composition of the superficial,
transition, calcified cartilage, and osseous zones of osteochondral tissues. The microstructure
of multidirectional scaffolds was characterized and the ability of these scaffolds to promote
osteochondral differentiation of progenitor cells was assessed using a novel transgenic multireporter cell platform. Zonal osteogenic differentiation of bone marrow stromal cells was
confirmed by transition of pre-osteoblast marker BSP-GFPtopaz to late osteoblast/early
osteocyte marker DMP1-RFPmCherry. Conventional histological and gene expression analysis
corroborated fluorescence data. Zonal chondrogenesis of triple transgenic articular
chondrocytes harboring reporters for fibrocartilage (Col3.6-GFPtopaz), articular cartilage
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(Col2a1-GFPcyan), and hypertrophic (Col10a1-RFPmCherry) lineages was assessed and
corroborated in a similar manner. Though the majority of fluorescent cells (65%) remained of
articular origin, there was a progression (28%) towards a pre-hypertrophic phenotype.
Combined with fluorescent reporter information, gene expression, histological, and
immunohistochemical analyses, subtle differences in zone-specific cellular phenotype and
newly-formed tissue were identified. Upon ectopic implantation in mice for 8 weeks, prehypertrophic cell populations terminally matured into mineralized tissue. Together, these data
suggest that multidirectional zonal scaffolds hold promise for clinical use in directing zonal
osteochondral repair by articular chondrocytes.
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Chapter 1
Introduction
1.1 Articular joint injury
Osteochondral tissue injury presents a major clinical challenge and attributes to the leading
cause of disability in the United States, osteoarthritis, which is projected to affect 67 million
people by 2030 in the United States alone.[1] This issue is further compounded by the innate
poor healing potential of chondral tissue due to its low cellularity and avascular composition
Bone, on the other hand, actively remodels in response to injury due to exposure to nutrients,
progenitor cells, and growth factors present in the vasculature (Figure 1.1).[2,3] Current surgical
techniques for osteochondral tissue repair are limited, and all have their unique benefits and
drawbacks. Microfracture, perhaps the most common technique, involves the creation of holes
between 0.5-1 mm in diameter at the exposed subchondral bone surface to withdraw bone
marrow progenitor cells into the defect cavity. The wound is then closed, and the resultant
repair tissue is often composed of fibrocartilage, a tissue functionally inferior to mature hyaline
cartilage. Over time, the fibrous tissue will deteriorate and mandate the need for additional
treatment; microfracture is merely a palliative procedure.[4] Restorative treatments include
mosaicplasty and autologous chondrocyte implantation (ACI). Mosaciplasty involves the
implantation of osteochondral autografts or allografts into the defect site. Though the repair
tissue is often hyaline-like, the technique is associated with significant donor-site morbidity and
a two-step surgical approach. ACI involves the harvest and expansion of autologous
chondrocytes and subsequent implantation into the defect. Like mosaicplasty, the repair tissue
is often composed of mature cartilage, but the technique is limited by a two-step surgery and
the intensive time and cost of chondrocyte expansion.[4,5]
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Figure 1.1 Bone’s putative healing capacity vs. cartilage’s intrinsic inability to heal.[3]

1.2 Structure and function of osteochondral tissue
When attempted to regenerate given biological system, it is critical to understand the structure
and corresponding function of the chosen tissue. Osteochondral tissue is a unique system in
that is biphasic, being composed of articular cartilage fully integrated into subchondral bone.
Articular cartilage is composed of collagen (90-95% type II collagen), proteoglycans,
chondrocytes (1% of tissue volume), and tissue fluid (80% of wet weight).[6] The overlying
articular cartilage is spatially organized into four distinct zones: the superficial (SZ),
intermediate, or transition zone (TZ), deep (DZ), and calcified cartilage zone (CCZ) (Figure 1.2).
The SZ consists of densely packed, highly aligned type II collagen fibers, the lowest
concentration of proteoglycans throughout the multiple zones, and flattened chondrocytes that
secrete the lubricating molecule PRG4.[7,8] The parallel collagen fiber orientation combined with
the unique phenotype of SZ chondrocytes confers a highly lubricious, high tensile strength
surface for opposing joint articulation.[7] The TZ consists of randomly oriented type II collagen,
intermediate proteoglycan concentration, and rounded chondrocytes. In the DZ, chondrocytes
are of columnar orientation, collagen fibers are oriented perpendicular to the surface and

2

present at the lowest concentration, and proteoglycan concentration is at its highest. A wavy
tidemark separates the DZ and CCZ, below which vertical collagen fibers become mineralized
and anchor into the subchondral bone. Importantly, the structure and composition of each
zone confers zone-specific properties to the embedded chondrocytes, which contribute to the
overall function of osteochondral tissue.[9] The subchondral bone is a composite tissue of type I
collagen and hydroxyapatite (HA) mineral, where the collagen confers the tissue with its
flexibility and tensile strength, and the hydroxyapatite mineral lends rigidity.[10] A characteristic
feature of the tissue is its ability to consistently remodel in homeostasis, due to an interplay
between bone-matrix-secreting osteoblasts and bone-resorbing osteoclasts.[11]

Figure 1.2: Illustration of zonal anatomy of articular cartilage (left) and hematoxylin and eosinstained section of rabbit articular cartilage (right). Scale bar length is 100 µm.[4]

The articular cartilage primarily functions to support near-frictionless movement of an opposing
joint surface. This ability is largely conferred by the high water content of the tissue combined
with the high concentration of negatively-charged proteoglycans (e.g. aggrecan). Much of the
tissue’s water is bound to proteoglycans, which largely contribute to the viscoelastic
mechanical properties the tissue exhibits.[12] The tissue’s proteoglycans also serve to bind
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cations, which establishes an osmotic pressure gradient to maintain a swollen state.[13]
Furthermore, the nano-porous collagenous extracellular matrix prevents the loss of water
under loading, generating frictional drag. The arcade-like organization of this matrix contributes
to bulk mechanical function. The arcade-like orientation of constituent collagen fibers helps
facilitate load dissipation across the tissue. As previously, mentioned, the laterally-aligned SZ
provide the tissue with high shear strength. The underlying TZ and DZ function to support
compressive loading, where compressive strength is greatest in the DZ where collagen content
is greatest and fibers are orthogonally-orientated to the compressive load. Compressive
strength is greatest in the CCZ, which functions as a barrier to prevent osteogenesis in the
cartilage by serving as a semi-permeable membrane to morphogens.[14–17]

The subchondral bone is intimately associated with the overlying articular cartilage both
physiologically and mechanically. There is growing evidence that osteoblasts in the
subchondral bone secrete molecular signals that influence the phenotype of overlying
chondrocytes, and vice-versa.[18,19] The mechanical function of the subchondral bone is to
anchor the overlying cartilage and absorb most of the applied load.[20] Compositionally, bone
consists of three primary components: type 1 collagen, carbonated HA and water. An
important remark made is that there is no one meaning to the ‘structure of bone.’ Rather, one
must consider the relevant hierarchical level of organization (Figure 1.3). Type 1 collagen fibrils
polymerize into a quarter-stagger arrangement, with plate-like HA present in 67 nm spacedgaps between fibrils and aligned along their longitudinal axes. These mineralized fibrils order
into compact bundles to form fibril arrays, which organize into lamellar patterns. These
patterns then organize cylindrically into osteons. Macroscopic cortical and trabecular bone
structures are considered at the sixth level, which contribute to whole bone at the final level.
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This structural complexity allows for the tissue to withstand various kinds of stresses in
multiple directions.[10]

Figure 1.3: Seven hierarchical levels of bone[10]

1.3 Biomaterials and tissue engineering
Due to the limitations of current treatment approaches, there exists an unmet clinical need for
an off-the-shelf strategy that induces functional osteochondral tissue without the
aforementioned drawbacks. Tissue engineering is a relatively new field that is actively meeting
this need. Tissue engineering, as defined by Langer and Vacanti in Science in 1993, is “...an
interdisciplinary field that applies the principles of engineering and the life sciences toward the
development of biological substitutes that restore, maintain, or improve tissue function.”[21]
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Tissue engineering is founded upon the classic paradigm involving the integrated use of cells,
morphogens (i.e. regulatory signals), and biomaterials (Figure 1.4). An optimal cell source is
selected, which may be of autologous or allogenic origin. These cells will then be seeded atop
or encapsulated within a biomaterial, which serves to support new tissue formation by the
applied cells. Further, morphogens, commonly in the form of growth factors or cytokines, are
commonly applied the cell-biomaterial construct to instruct the cells to perform a particular
function.[21,22] In personalized treatments, a patient’s cells may be harvested, expanded ex vivo
to obtain a required amount of cells, seeded atop a biomaterial combined with morphogens,
and cultured in vitro for a select period of time to mature the construct to a level deemed
optimal for ultimate tissue formation in vivo. This construct may then be implanted in the site of
injury to restore, maintain, or improve tissue function.

Figure 1.4 Tissue engineering paradigm involving the combination of biomaterials, cells, and
regulatory signals to instruct new tissue formation.[22]
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Selection of the appropriate biomaterial, cell source, and/or morphogen(s) is not a trivial
matter. There exist abundant criteria that must be met for successful neo-tissue formation in
vivo. Biomaterials must first and foremost be cytocompatable. Further, they must have suitable
mechanical properties to support the proliferation/differentiation of the cell source. Additionally,
they must support adequate nutrient diffusion by having a porous architecture of defined pore
size. These materials must have a degradation behavior that matches the rate of new tissue
ingrowth. Of course, other criteria for optimal biomaterials exist, and depend on the target
application.[23–25]

Biomaterials may be constructed from a plethora of synthetic or natural materials, comprised
of ceramics, polymers, and metals. Biodegradable materials are of particular interest in tissue
engineering of osteochondral tissue, so polymers are often chosen. Synthetic polymers have
the advantage of being biologically inert, having tunable degradation rates, and ease of
processing. Clinically approved co-polymer poly(lactic-co-glycolide), for example, possesses
chemical properties that allow for tunable degradation rates based on the ratio of lactic to
glycolic acid monomers; the greater the lactic acid content, the less hydrophilic the polymer,
and the longer the degradation time. PLGA, like many synthetic polymers, degrades into acidic
byproducts (poly(lactic acid) and poly(glycolic acid)) through hydrolysis, which may prove
cytotoxic to the local tissue environment targeted for regeneration.[26] Many natural polymers,
on the other hand, possess inherent cell-binding motifs, may instruct cell signaling, and
degrade into non-toxic by products.[23,27] For these reasons, natural polymers are often better
suited for tissue repair.
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1.4 Biomaterials for osteochondral tissue engineering
1.4.1 Clinically-used biomaterials
A wide variety of clinically-approved biomaterials exist with a targeted indication for treatment
of articular-joint related trauma and/or disease. Representative of this device space are de Novo
NT (Zimmer) and MACI (Genzyme), and MaioRegen (Finceramica).[28,29] De Novo NT is an allograft
that consists of particulated juvenile chondrocytes indicated for treatment of symptomatic
articular cartilage defects for patients between the ages of 18 to 55. The product relies on the
assumption that chondrocytes are able to migrate from the particulate cartilage into the defect
site to support new tissue formation.[30] This treatment is hampered by necessity to use the
device shortly after chondrocyte collection. Moreover, arthroscopic implantation of the de Novo
NT particulates into the talus of 46 patients demonstrated a fibrocartilage repair associated with
persistent hypertrophy after 24 months.[31] MACI (matrix-assisted autologous chondrocyte
implantation) is an advancement on ACI treatment, where autologous chondrocytes are
implanted on a type 1/type 3 porcine collagen membrane, implanted in the defect space, and
covered with a fibrin sealant.[32] Both radiographic and histological measures of newly-formed
tissue show promising hyaline-like cartilage, though the long-term stability of the technology is
questionable.[32,33] Of course, both treatments are indicated for restoration of just the articular
cartilage, calling for the necessity of biphasic materials that may direct simultaneous
regeneration of both chondral and osseous tissue.

1.4.2 Zonal biomaterials
At the current moment, a limited product space of clinically-available biomaterials aimed for
the restoration of osteochondral tissue exist. MaioRegen is a notable multi-layered device
targeted for osteochondral repair that has been widely-studied. Its design is intended to
mimic the composition of osteochondral tissue; it is a tri-layered sponge, consisting of an

8

upper chondral layer of 100% equine type 1 collagen, an intermediate calcified layer of 60%
equine type 1 collagen and 40% magnesium-enriched HA, and an underlying osseous layer of
30% equine type 1 collagen and 70% magnesium-enriched HA (Figure 1.5).[29]

Figure 1.5: MaioRegen (FinCeramica) tri-layered osteochondral graft.[29]

The device is recommended for use with bone-marrow stimulation techniques, with the aim to
direct the spatial differentiation of infiltrating progenitor cells.[29,34] This material has been
extensively studied in pre-clinical models, though the efficacy of the material is controversial;
though a number of reports by one group claim good tissue infill and positive clinical
outcomes,[35–37] a recent study in humans showed poor biological repair of both chondral and
osseous tissue up to three year post-operatively.[38] Similarly, incomplete osteochondral repair
at two years was reported upon radiographic evaluation of a commercially-availavble biphasic
scaffold comprised of PLGA (chondral phase) and PLGA and calcium sulfate (osseous phase)
(TruFit CB, Smith & Nephew).[39] A review of osteochondral defects treated with TruFit revealed
no data in support of either equality or superiority of the device compared to mosaicplasty or
microfracture treatments.[40] Clearly, there exists a need for well-designed compartmentalized
scaffolds that can yield repair of functional, zonally organized osteochondral tissue.
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Accordingly, interest in the development and characterization of advanced zonal biomaterials
for osteochondral tissue engineering has been gaining momentum.[41–55]. To fabricate such
scaffolds, investigators have been turning to hydrogels, 3D printed matrices, and freeze-cast
sponges. Hydrogels consist of crosslinked water-swollen polymer chains that retain a large
volume of water due to their polar functional groups.[56] A unique property to hydrogels are their
ability to undergo a sol-gel transition in the presence of a crosslinking agent, making it possible
for cell encapsulation or shaping irregular defects.[57] Moreover, these materials have
extensively been used in 3D printing, cell encapsulation, and drug delivery applications.[58–60]

A notable example of zonal hydrogel design was reported by Zhu et. al., where hydrogels
exhibiting a stiffness gradient mimicking that of natural cartilage tissue were generated by
sequential photopolymerization. Varying stiffness was generated by altering the content of
hydrogel polymer poly(ethylene glycol) (PEG), where stiffer regions contained higher
concentrations of PEG. A continuous feed of PEG solution with bovine primary chondrocytes
was delivered into a mold, which was then subject to UV photopolymerization. The resulting
gels were used to study the influence of continuous stiffness gradient on zonal matrix
deposition by encapsulated chondrocytes. The chondrocytes were found to express increasing
type 2 collagen and aggrecan with increasing scaffold stiffness, mimicking the compositional
gradient of natural cartilage tissue.[52]

3D printing, or additive manufacturing, allows for the layer-by-layer fabrication of biomaterials
from a computer-aided design (CAD) file of the desired structure.[61] Di Lica and colleagues
recently reported the generation of 3D printed poly(e-caprolactone) (PCL) scaffolds with
encapsulated human mesenchymal stem cells (hMSC) that contained a gradient in pore shape
with scaffold depth. Pore shape was controlled by altering the angle between adjacent PCL
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strands to achieve five pore shape zones: 15º, 30º, 45º, and 90º (orthogonal mesh). The
platform successfully served as a tool to study hMSC chondrogenic and osteogenic
differentiation in response to pore shape. Ultimately, it was revealed that orthogonal pores
better supported chondrogenic differentiation, while rhombohedral pores (15º/30º) better
supported osteogenic differentiation. The observed differences may have been from
differences in oxygen availability influenced by the varied pore tortuosity.[55]

Lyophilization, or freeze casting, is a versatile technique that relies on the nucleation and
growth of a solidified solvent to template the pore structure. Upon sublimation, void space
replaces the solidified solvent, yielding interconnected porosity. Further, control of the pore
size may be controlled by adjusting the freezing temperature.[62] Levingston et. al. leveraged
this approach to generate tri-layered collagen-based scaffolds that mimicked compositions of
osseous, calcified cartilage, and chondral tissues. Tri-zonal scaffolds were fabricated by
separately preparing chondral, calcified cartilage, and osseous suspensions, followed by
iterative lyophilization of each suspension. The osseous suspension, consisting of bovinederived type 1 collagen and HA in 0.5 M acetic acid, was first spread in a cylindrical mold and
lyophilized under defined conditions. A calcified cartilage suspension containing type 1
collagen type II collagen, and HA in 0.5 M acetic acid was then layered atop the ore-fabricated
osseous sponge and lyophilized. This process was then repeated with a chondral suspension
containing type 1 collagen, type 2 collagen, and hyaluronic acid (HYA).[15] This iterative
lyophilization process led to the formation of a tri-layered scaffold with interconnected porosity
and three discrete scaffold zones (Figure 1.6). This paper evinces the ease and versatility of the
freeze casting process for zonal scaffold design.
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Figure 1.6: Tri-zonal scaffold fabricated by iterative freeze casting.[15]

Despite these notable efforts in zonal biomaterial design, limited work has been reported on
the design and characterization of zonal osteochondral scaffolds that mimic both the zonal
structural and compositional anisotropy of native osteochondral tissue.[53] Recapitulation of the
native ECM collagen fiber architecture is critical. Isotropic matrices fail to provide the
appropriate zonal mechanical properties and cellular cues, which likely results in regenerated
tissue lacking zonal organization and hyaline character.[63] To fill this gap, we propose the
development of monolithic biomaterials that mimic both the structural anisotropy and chemical
composition of osteochondral tissue. In fulfillment of this objective, we seek to leverage the
platform of unidirectional freeze casting to achieve these zonal properties.
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Fig. 3. Typical microstructures obtained by freeze-casting (a) porous alumina using an
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ADVANCED ENGINE

The unit cell of ice structure displays a high degree of order with six-fold symmetry. Moreover,
the unit cell is hexagonal and contains a loosely packed arrangement of water molecules.[68]
Importantly, crystal growth along the unit cell’s a-axis is substantially faster than along its c
axis. Consequently, the thickness of the growing crystal remains small while comparatively
rapid uniaxial growth along the c-axis yields an arrangement of vertical, lamellar crystals.
Additionally, crystals that have a-axes aligned in the direction of the applied temperature
gradient possesses a lower free energy than crystals with a-axes perpendicular to the gradient,
further resulting in rapid uniaxial growth.[62] In total, these kinetics contribute to the microscopic
lamellar structure formed (Figure 1.7c) when ice is employed as the crystallizing solvent. Other
unique pore geometries can be achieved by using solvents with different crystallization
behaviors (e.g. camphene).[69]

At some point during the onset of solidification, a transition between a planar to a cellular
interface of a given wavelength results. Its formation is related to a growing thermodynamic
instability of the planar interface (i.e. Mullins-Sekerka Instabilities)[70] in the presence of adjacent
particles; the applied thermal gradient becomes inverted between the growth front and the
adjacent particle.[62]

Perhaps the greatest degree of control over the resultant pore structure can be attained
through the way in which one applies a temperature gradient during solidification. If no
temperature gradient is applied and cooling is uniform throughout the material, ice crystal
nucleation will occur randomly throughout the material, yielding a completely isotropic scaffold.
In contrast, if a temperature gradient is applied unidirectionally (e.g. if cooling is initiated on the
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bottom surface of the mold only), the growth front will proceed vertically, yielding an aligned,
anisotropic lamellar network (Figure 1.8).[71] Pore size (or interlamellar spacing for unidirectional
specimens) may be controlled by altering the degree of undercooling ahead of the advancing
solidification front.[62,71,72] This may be conferred by undergoing a rapid cooling regime. Since
the interlamellar spacing is inversely proportional to the solidification front velocity, pore size
can be tightly controlled.[62,66]

Figure 1.8: Unidirectional solidification of a ceramic slurry.[71]

Thus, by leveraging the simple fact that ice grows from regions of high temperature to those of
low temperature, unique pore geometries can be created through smart mold design
controlling the heat distribution in the slurry during solidification.

Research objectives
It is the aim of this work to fabricate a biomaterial that mimics the zonal architecture and
composition of native osteochondral tissue and evaluate its potential for clinical use. This
scaffold may coerce infiltrated stem or progenitor cells to rebuild mature hyaline cartilage and
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subchondral bone tissue. To accomplish this aim, type 1 collagen and hyaluronic acid (HYA)
will be used to construct the chondral component of the tissue, while type I collagen and
hydroxyapatite (HA) will comprise the osseous compartment. Type 1 collagen, a fibrous
structural protein abundant in human ECM, will be used due to its cytocompatability,
possession of cell binding peptides, and high tensile strength, resorbability, and extensive use
in osteochondral scaffold design.[35,73–78] Furthermore, type 1 collagen is often chosen over type
2 collagen due to its ease of isolation and stronger mechanical properties.[15] HYA is one of the
main glycosaminoglycans present in cartilage and is responsible for maintenance of water
equilibrium due to its strong negative charge, management of viscoelastic properties, and
attracts chondrocytes due to recognition sites for cell receptors CD44 and RHAMM.[79–81] It has
been used extensively in the cartilage tissue engineering field and shown to induce early-stage
chondrogenesis of mesenchymal stem cells (MSCs).[15,80,81] HA, Ca5(PO4)3(OH)2, is the inorganic
component of bone and constitutes 50-70 wt% of bone mass.[11,82] HA is extensively used in
osteochondral and bone tissue engineering applications due to its cytocompatability,
resorbability, rigid mechanical properties, and osteogenic ability.[15,43,45,83–85] Specifically, HA has
been shown to induce osteogenesis of MSCs through the release and subsequent intracellular
uptake of PO43- ions.[86] The combination of type 1 collagen with chondrogenic (HYA) and
osteogenic (HA) materials holds great potential in orchestrating de novo tissue formation.

The objective of this research can be broken down into three aims: (1) establish an optimal
freeze casting platform for the fabrication of unidirectional collagen-based scaffolds, (2)
leverage unidirectional freeze casting to design monolithic multizonal scaffolds that mimic the
orientation and composition of native osteochondral tissue, and (3) evaluate the ability of these
multizonal scaffolds to support osteochondral differentiation of seeded progenitor cells in vitro
and in vivo. The subsequent chapters address fulfillment of these objectives.
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Chapter 2
Establishment of an optimal freeze casting platform for the fabrication of unidirectional
collagen scaffolds

2.1 Introduction
Lyophilized collagen scaffolds have been instrumental in the regeneration of a variety of
tissues.[15,78,87–91] Freeze-casting is a lyophilization-based process that affords the biomaterial
with an interconnected porous structure that is a replica of the previously frozen collagen
suspension. The method involves freezing an aqueous colloidal suspension, where the ice
crystals trap the incorporated polymer into a binary network. The structure is then lyophilized
to yield a pore negative of the ice network. Because the process is driven by the freezing of the
suspension, minimal harm to the protein is conferred as harsh solvents are not required in the
process.[8,9] Furthermore, one may easily control the geometry of the resulting scaffold through
manipulating the nucleation and growth of ice crystals in the freezing medium by imposing
temperature gradients on the suspension.[85,87]

Despite the ease of the freeze-casting process, a number of problems may arise that
compromise the structural integrity and function of the biomaterial. Structural collapse may
occur if the sublimation process is not optimized and can destroy the product’s structure and
function.[92,93] If a material’s temperature exceeds its frozen-state glass transition temperature
(Tg’), viscous migration of the suspension components will be enhanced, destroying the
structure created during the freezing stage.[93] Tg’ is closely tied to its collapse temperature
(Tcol), typically higher by 1-3ºC.[94] Collapsed structures feature prominent structural deformation
in the form of buckling, shrinking, discoloration, and increased moisture content.[93] In the
pharmaceutical literature, it is well accepted that a material’s temperature should be kept
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under its Tg’ during primary drying (sublimation at low temperature and pressure to remove
frozen water) to avoid collapse.[94–96] However, minimal connection has been made to tie these
concepts to the biomaterials and tissue engineering community. Furthermore, to the best of
our knowledge, product collapse has not been detailed in the context of the widely used
biomaterial system of collagen and acetic acid. It is crucial to gain an in-depth understanding
of the collapse mechanism in order to produce acceptable collagen-based scaffold materials.

It is the aim of this study to investigate product collapse in the context of unidirectionally freeze
cast collagen scaffolds and propose a strategy to mitigate this issue during primary drying that
extends to collagen-acetic acid system. To this end, unidirectionally-freeze cast collagen
scaffolds were fabricated, where the effects of solvent concentration and lyophilizer shelf
temperature on scaffold structural integrity and collapse were investigated. Finally, a
mechanism of product collapse is proposed.

2.2 Materials and methods
2.2.1 Preparation of collagen slurries
Insoluble type I collagen derived from bovine Achilles tendon (Sigma-Aldrich, USA) was
dispersed at 1 wt% into solutions of either 0.5 M or 0.05 M acetic acid (HAc) (Certified ACS,
Fisher Scientific, USA) in deionized H2O (dH2O) and stirred at 4ºC overnight. Collagen
Suspensions were homogenized with a hand-held homogenizer (Omni TH, Omni International,
Kennesaw, GA) over ice for 15 minutes then degassed in a vacuum desiccator while stirring for
30 minutes.
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2.2.2 Unidirectional freeze casting of collagen slurries
Degassed collagen slurries were withdrawn into 5 cc syringes with 10 gauge needle tips and
dispensed into rectangular poly(methyl methacrylate) (PMMA) molds (Figure 2.1).

Figure 2.1: Side-view (A) and isometric-view (B) photographs of PMMA mold used to
unidirectionally freeze collagen suspensions. PMMA was used as a transparent insulator to
confer a temperature gradient along the length of the mold. A copper base-cap was sealed at
one end of the mold to thermally conduct the cold source (dry ice) to the suspensions.

Slurries were placed directly atop dry ice in a Styrofoam box and unidirectionally solidified for
30 minutes. Frozen samples were left in molds and placed in a lyophilizer (Freezone 6,
LABCONCO, Kansas City, MO) equilibrated to a shelf temperature of either -25ºC or -40ºC to
freeze for one day. A vacuum was then pulled to 0.03 mBar for 3 days.

2.2.3 Field emission scanning electron microscopic examination of lyophilized scaffolds
To investigate the effect of solvent concentration and shelf temperature on scaffold structure,
digital photographs of as-cast scaffolds were taken alongside stitched field emission scanning
electron microscopic (FESEM) panoramas of entire scaffold faces. Lyophilized scaffolds were
sputter-coated (Polaron E5100, Quorum Technologies, UK) with a Au-Pd target for 45 seconds.

19

Scaffold surfaces were observed using field emission scanning electron microscopy (JSM6335F, JEOL, Peabody, MA) at an accelerating voltage of 5 kV. Images were allowed to overlap
by ≥ 25% and stitched together using FIJI plugin MosaicJ.

2.2.4 Porosity quantification of FESEM images
Percent surface porosity was quantified using FIJI. Four 400 x 400 pixel regions were analyzed
per region of the scaffold (bottom, middle, and top). The contrast of each image was
enhanced. Each image was then binarized and thresholded to yield scaffold structures black
and pores white. A black and white pixel histogram was produced, where percent surface
porosity was determined with the following equation:
𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝑆𝑢𝑟𝑓𝑎𝑐𝑒 𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 =

# 𝑊ℎ𝑖𝑡𝑒 𝑃𝑖𝑥𝑒𝑙𝑠
× 100
# 𝑊ℎ𝑖𝑡𝑒 𝑃𝑖𝑥𝑒𝑙𝑠 + # 𝐵𝑙𝑎𝑐𝑘 𝑃𝑖𝑥𝑒𝑙𝑠

Percent surface porosity values were averaged for all four image samples taken per scaffold
region.

2.2.5 Differential scanning calorimetry of collagen slurries
Modulated differential scanning calorimetry (MDSC) (DDSC Q-100, TA Instruments, Newcastle,
DE) was performed on collagen slurries in 0.5 M and 0.05 M HAc to identify the glass transition
temperature of the frozen product (Tg’). Slurry quantities of 20-30 mg were loaded into
aluminum-hermetic pans, equilibrated to -90ºC, held isothermally for 60 min, and ramped at
2ºC/min to 20ºC. A modulation amplitude of ± 0.5ºC/min and period of 60 seconds were
applied.
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2.2.6 Temperature profile monitoring of collagen slurries during sublimation
To study the product temperature over the drying process, slurry volumes of 1.5 mL in 0.5 M
and 0.05 M HAc were placed into PMMA molds with thermocouples inserted. Slurries were
frozen for 30 minutes over dry ice, then inserted into the lyophilizer chamber equilibrated to a
shelf temperature of either -25ºC or -40ºC for three hours. Slurry temperatures were recorded
during three days of sublimation at 0.03 mBar. A computer was used to record slurry
temperatures every 10 seconds.

2.2.7 Statistical analysis
Statistical differences in percent porosity between scaffold regions were analyzed with oneway ANOVA with a post-hoc Tukey Test. Statistical significance was considered at p < 0.05.

2.3 Results
2.3.1 FESEM examination of lyophilized scaffolds
All lyophilized scaffolds consisted of highly aligned collagen fibers (Figure 2.2), conferred by
the temperature gradient. The direct contact of the thermally conductive copper-base cap with
the dry ice led to quick freezing (~ 20 minutes) while the use of the PMMA insulator and
exposed slurry top imposed a temperature gradient along the length of the slurry, which led to
a uniaxial solidification front.
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Figure 2.2: Photographs (A-D) and FESEM micrographs (A1-D4) of unidirectionally freeze cast
scaffolds sublimed at shelf temperatures of -25ºC and -40ºC from 0.5 M or 0.05 M HAc-based
slurries. A1, B1, C1, and D1 show the stitched bulk view of the microstructures, evincing
varying degrees of structural collapse. A2-D4 are higher magnification micrographs of the top
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(A2, B2, C2 and D2), middle (A3, B3, C3 and D3), and bottom (A4, B4, C4 and D4) of the outer
surface of scaffolds. Black arrows in B note wrinkling.

Following three days of lyophilization at a shelf temperature of -25ºC, scaffolds created from
both 0.5 M and 0.05 M HAc displayed significant collapse in the bulk product (Figure 2.2, A
and C). Features of collapse considered are buckling (lateral deformation) and wrinkling
(surface indentations). The stitched electron micrograph panorama details extensive buckling,
most prominent near the center of the structure (A1, C1). Higher magnification images (A2-A4,
C2-C4) reveal that a mostly non-porous skin layer has been formed on the surface of the
scaffold created from both 0.5 M and 0.05 M HAc suspensions at a shelf temperature of -25ºC.
It was observed that the middle (A3, C3) and bottom (A4, C4) regions possessed a skin layer
on the surface of the scaffold. In contrast, when a lower shelf temperature (-40ºC) was
employed, structural deformation was largely avoided for scaffolds from both 0.5 M and 0.05
M HAc suspensions. Photographs (B, D) reveal a lessened extent of collapse for both 0.5 M
and 0.05 M HAc-based scaffolds compared to their -25ºC counterparts. Stitched panorama
scanning electron micrographs (B1, D1) show minimal buckling along the entire length of the
materials. Importantly, the 0.5 M HAc-based scaffold displayed wrinkling (blue arrows, B),
whereas the 0.05 M HAc-based scaffold did not. Apparent wrinkles in the 0.05 M HAc-based
scaffold (D) are determined to be features of surface roughness attributed to the open-pore
surface. Higher magnification reveals a more open structure for the material created from 0.05
M HAc (B2-B4) compared to 0.5 M HAc (C2-C4). The use of the -40ºC chamber temperature
(B1, D1) appeared to eliminate scaffold buckling, reduce wrinkling, and lead to a more open
surface compared to -25ºC (A1, C1) for both acid concentrations.
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2.3.2 Porosity quantification
Figure 2.3 presents percent surface porosity of bottom, middle, and top regions for all scaffold
groups. All regions from scaffold groups 0.5 M, -25ºC, 0.05 M, -25ºC, and 0.5 M, -40ºC
exhibited significantly less percent surface porosity to their corresponding regions of the 0.05
M, -40ºC group. Additional statistical difference was found for top regions between 0.5 M, 25ºC and 0.05 M, -25ºC groups.

Figure 2.3: Percent surface porosity of bottom, middle, and top regions of scaffold surfaces.
Scaffolds created from both 0.5 M and 0.05 M HAc are compared, along with -25ºC and -40ºC
shelf temperatures. Statistical significance (*) is considered at p < 0.05.

2.3.3 Differential scanning calorimetry of collagen slurries
Distinct Tg’ endotherms were observed for both 0.5 M and 0.05 M HAc-based slurries (Figure
2.4A and B, respectively). The samples were heated from -90ºC to 20ºC. The MDSC scan
revealed Tg’ of -26.2ºC and -28.5ºC for 0.5 M and 0.05 M HAc-based slurries, respectively.
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Figure 2.4: MDSC scans for 0.5 M (A) and 0.05 M (B) HAc-based collagen slurries. Tg’
endotherm for B is presented in the inset.

2.3.4 Collagen slurry temperature profile
Figure 2.5 displays material temperatures as a function of time during sublimation at shelf
temperatures of -25ºC and -40ºC for both 0.5 M and 0.05 M HAc-based slurries.
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Figure 2.5: Temperature profiles during primary drying at shelf temperatures of -25ºC (A) and 40ºC (B) for 0.5 M and 0.05 M HAc-based collagen slurries. Dotted lines indicate respective
Tg’s for 0.5 M and 0.05 M HAc-based slurries. Chamber pressure is plotted in green on the
secondary y-axis.

During sublimation at both temperatures, all materials experienced a rapid decrease in product
temperature coinciding with the decrease in chamber pressure (atmosphere to 0.03 mBar) as
the vacuum was being applied. As the chamber pressure reached its set value of 0.03 mBar, all
material temperatures increased until plateauing to a final value. At a shelf temperature of 25ºC (Figure 2.5A), 0.5 M and 0.05 M HAc-based slurries displayed initial temperatures of 12ºC and -14ºC, respectively, rapidly increased in temperature, and plateaued to -11ºC and 12ºC after three days of primary drying. For a shelf temperature of -40ºC (Figure 2.5B), 0.5 M
and 0.05 M HAc-based slurries displayed initial temperatures of -29ºC and -30ºC, respectively.
Product temperatures for both slurries increased over the course of the three-day sublimation
period. 0.5 M and 0.05 M HAc-based slurries reached -24ºC and -26ºC, respectively, after
three days of drying.
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2.4 Discussion
This study presents two main findings: (1) the use of 0.05 M HAc facilitated the formation of a
porous surface at -40ºC and (2) keeping material temperatures below their Tg’ is critical to
prevent structural collapse.

Though freeze casting is a technically facile process, care must be taken to ensure the final
dried product retains its desired properties post-sublimation. It is during this stage that
significant structural deformation may result, significantly compromising the material’s function
and upstream processing ability. At the initial stages of drying, heat is removed from the
product as ice is converted to vapor. As the product begins to dry, resistance to vapor
diffusion through the product is created, leading to an increase in vapor pressure and
subsequent increase in product temperature.[92,97] The relationship between product
temperature and its vapor pressure is described by the following expression:[98]
𝑙𝑛𝑃 =

−6144.96
+ 24.01849
𝑇

(1)

where T is absolute temperature of the product and P is the vapor pressure of ice in mm Hg.
Thus, with increasing vapor pressure, product temperature rises.

Subliming frozen collagen suspensions in both 0.5 M and 0.05 M HAc at -25ºC (Figure 2.2A, C)
yielded scaffolds with a collapsed structure and a mostly non-porous skin. This dense layer led
to incomplete drying of the material’s interior and rendered upstream processing difficult.
Slight evidence of structural collapse was observed with 0.5 M HAc (Figure 2.2B, black
arrows). The use of 0.05 M HAc at -40ºC led to a porous surface with little evidence of
structural collapse (Figure 2.2D). In acidic conditions, collagen swells due to osmotic pressure
differences between the protein and the surrounding medium.[99] Furthermore, at lower pH (pH
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= 2.5 in the 0.5 M HAc collagen suspension), more water is bound to the collagen molecules
than at higher pH (pH = 3.02 in the 0.05 M HAc collagen suspension), leaving less water
subject to crystallization.[100] As a result, a less porous structure is formed in the 0.5 M HAc
sample. This information corroborates the results in Fig 3, with all regions of the 0.05 M HAcbased scaffold sublimed at a shelf temperature of -40ºC displaying the greatest surface
porosity. A combination of minimal swelling of collagen fibers with minimal collapse owed to
the use of the -40ºC shelf temperature promoted formation of the open surface.

It was hypothesized that the observed product collapse was due to material temperatures
rising above their Tg’. To confirm this, MDSC was performed on both 0.5 M and 0.05 M HAcbased slurries. Because collagen does not undergo crystallization during the MDSC profile, the
endotherms of -26.2ºC and -28.5ºC for 0.5 M and 0.05 M HAc-based suspensions,
respectively, must be the Tg’ of the materials. Haugh et al. reported a reduction of viscosity of a
0.5 wt% collagen suspension in 0.05 M HAc at -42ºC through dynamic thermal analysis.[101] The
discrepancy between this temperature and our Tg’ could be explained by the higher collagen
content (1 wt%) in our system; increasing protein content results in the increase in Tg’.[96]
Furthermore, the Tg’s identified are in good agreement with the Tg’ reported for a similar system
of poly(lactide-co-glycolide) in HAc (Tg’ = -28.4ºC).[102] The broad endotherm that follows both
Tg’s in Figure 2.4 can be attributed to melting of the bulk material.

Both slurry temperatures remained above their Tg’ after freezing at a shelf temperature of 25ºC, but persisted below this value for a shelf temperature of -40ºC. As the chamber pressure
was lowered at either temperature, both materials experienced rapid decreases in product
temperature presumably due to the removal of latent heat by the increased vacuum. At -25ºC,
both materials exceeded their Tg’ for the entire primary drying cycle, corroborating the SEM
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data in Figure 2.2. At -40ºC, product temperatures were significantly lowered, but did rise
above their Tg’. However, the 0.05 M formulation only exceeded its Tg’ for the last 20.83 hours
(28.93%) of the drying cycle, while the 0.5 M slurry exceeded its Tg’ for 52.91 hours (73.49%)
of the cycle. Moreover, the 0.05 M slurry exceeded its Tg’ by a maximum of 2.5ºC, while the 0.5
M slurry surpassed its Tg’ by 4.2ºC. This data supports the observations in Fig 2, where the
evidence of collapse is observed in the 0.5 M slurry, compared to minimal deformation in the
0.05 M slurry.

It is important to consider how HAc concentration may be linked to product collapse. The
formation of a relatively non-porous surface through the use of 0.5 M HAc may increase the
resistance to vapor diffusion out of the scaffold, increasing the local vapor pressure, in turn
heating the product above its Tg’.[98] In addition, the concentration of HAc influences the
temperature and pressure at which sublimation is allowed to proceed. The use of higher
concentration acid, through colligative property, decreases the freezing point and increases the
boiling point by shifting the solid-liquid phase boundary left and liquid-gas phase boundary
right.[103] Figure 2.6 illustrates the effect of HAc concentration, with (Figure 2.6B) and without
(Figure 2.6A) collagen, on the pressure-temperature phase diagram for pure water.
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Figure 2.6: Influence of HAc concentration with (B) and without (A) collagen on solid-liquid and
liquid-solid phase boundary location on the pressure-temperature phase diagram for pure
water. Vapor pressures for 0.5 M HAc and 0.05 M HAc in water at 25ºC were calculated from
Raoult’s Law[104] and the Antoine Equation[105,106] and used as reference for phase boundary
locations in A. Freezing points of 0.5 M and 0.05 M HAc-based 1 wt% collagen slurries (B)
were experimentally determined and used as a reference in B.

At 25ºC, the addition of HAc lowers the total pressure of the system slightly from 31.73 mBar
to 31.72 mBar and 31.63 (values calculated using Raoult’s Law [23] with Antoine Equation
parameters for HAc[105] and water[106]) for 0.05 M and 0.5 M HAc concentrations, respectively.
As a result, the pressure and temperature required to cross from the solid to gas phase are
reduced, making it more difficult to sublime the product. If the local material pressure reaches
a value P1, the product can successfully transform from solid to gas for the 0.05 M HAc
system. For the 0.5 M HAc system, however, the system must first surpass the liquid phase,
leading to insufficient drying. The addition of collagen to the HAc-water system shifts the solid-
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liquid and liquid-gas phase boundaries even further (Figure 2.6B), resulting in a lower pressure
and temperature combination for sublimation to proceed. Freezing points of both 0.5 M and
0.05 M HAc-based 1 wt% collagen slurries (-9ºC and -8ºC, respectively) were experimentally
measured and used as references in Figure 2.6B. Like the HAc-water system in Figure 2.6A,
there exists a pressure P2 at which the 0.05 M HAc-collagen system can directly pass from the
solid to gas phase. However, the 0.5 M HA-collagen system cannot. In relevance of our
findings, it is possible that the local pressure of the material was near P2, allowing for sufficient
drying of only the 0.05 M HAc-based material. As a result, un-sublimed ice in the material may
have melted upon removal of the product from the lyophilizer as temperature increases, further
promoting collapse.

To avoid structural collapse in unidirectionally freeze cast collagen sponges, we propose the
use of 0.05 M HAc in the initial slurry formulation combined with drying at a temperature of 40ºC or below. A concentration of at least 0.05 M HAc is added to make a stable collagen
suspension; homogenization in pure dH2O was difficult and did not form a stable suspension in
our experiments. Furthermore, HAc induces constitutional undercooling ahead of the growing
solidification front during freezing, critical for the formation of plate-like ice crystals and,
subsequently, aligned collagen fibers.[107]

Ideally, materials should reach maximum temperatures at least 2 degrees below their Tg’ for
long drying times (> 2 days).[95] Unfortunately, we were limited to a minimum shelf temperature
of -40ºC due to the technical limitations of our freeze dryer. However, it is impractical to
perform primary drying at temperatures below -40ºC, as drying time increases with decreased
shelf temperature.[96] However, other steps could be taken to ensure product temperature
remains sufficiently under Tg’. Decreasing the material’s thickness could reduce resistance to
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vapor diffusion during sublimation, keeping the product’s temperature below that of its Tg’.
Altogether, eliminating excessive surface skin formation through proper pH control (use of 0.05
M HAc) combined with keeping the material sufficiently cool during drying (-40ºC or below
shelf temperature) are critical concerns to ensure an acceptable scaffold post-lyophilization.

2.5 Conclusions
This study demonstrated the impact of both HAc concentration and lyophilizer shelf
temperature on collapse of unidirectionally freeze-case collagen scaffolds. It was revealed that
keeping the materials temperature below that of its Tg’ is critical to prevent collapse, which can
be achieved through applying a sufficiently low shelf temperature (≤ -40ºC) during the
sublimation cycle and avoiding the use of low pH suspensions (0.5 M HAc). The employment of
these conditions may help ensure structural integrity and ultimate function of the polymer is
preserved post-lyophilization, accelerating future research endeavors using the common
collagen-acetic acid system.
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Chapter 3
Biomimetic multidirectional scaffolds for zonal osteochondral tissue engineering via a
lyophilization bonding approach

3.1. Introduction
Damage to articular cartilage, manifested by trauma or disease, is highly difficult to treat due to
the low cellularity and avascular composition of the tissue.[2,3] If left untreated, this damage
commonly progresses to the underlying subchondral bone resulting in osteoarthritis, a chronic
osteochondral disease that is projected to affect 67 million Americans by 2030.[1] Clinical
treatments are limited with autografting being the gold standard.[4,5] Other treatments options
(e.g. microfracture) are mostly palliative than restorative, yielding mechanically inferior
fibrocartilage which may deteriorate over time.[4] Altogether, a great clinical need exists for a
new strategy that mitigates the drawbacks of current treatment options.

Advanced biomaterial design for regenerative engineering of osteochondral tissue is an active
area of research that has shown great promise in meeting this unmet clinical need. When
considering the engineering of osteochondral tissue, it is critical to recognize the constituent
zonal organization, as this structure underlies the function of the tissue. Each zone varies with
respect to the orientation of the collagen framework and composition of extracellular matrix
macromolecules through depth of the tissue.[8,108] Despite this complex and specific
organization, the majority of biomaterials targeted for osteochondral repair are structurally and
compositionally isotropic; these fail to provide the cues necessary for engineering new tissue
with zonal organization and hyaline character.[63] Accordingly, there has been significant
interest towards the development of anisotropic matrices that recapitulate the zonal properties
of native osteochondral tissue.[15,46,54,63,109] Despite these efforts, there remain few reports of
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novel materials that mimic both the structural organization and chemical composition of the
tissue.

To fill this gap, we report here the facile and efficient production of monolithic multidirectional
scaffolds that mimic the structural and compositional anisotropy of native osteochondral
tissue. To accomplish this, unidirectional freeze casting is an attractive fabrication approach.
Directionality may be conferred to a material through the unidirectional growth of a solidifying
solvent under an imposed temperature gradient. Upon sublimation, the solvent is replaced by
interconnected porosity. The process is particularly advantageous as it excludes the use of
harsh solvents and allows for compositional control by adjustment of the initial suspension
formulation.[62,66]

In this work, the fabrication and characterization of multidirectional osteochondral scaffolds is
described, predicated on earlier work performed to establish an optimal unidirectional freeze
casting platform.[22] A lyophilization bonding process was developed that allowed for the
production of scaffolds that mimic both the architecture and composition of the superficial,
transition, calcified cartilage, and osseous zones. These zonal materials may aim to direct the
spatial differentiation of seeded progenitor cells into chondrocytes or osteoblasts and form
well-integrated osteochondral tissue that retains native zonal collagen orientation and
mechanical properties.

3.2 Materials and methods
3.2.1 Fabrication of multidirectional osteochondral scaffolds
To fabricate scaffolds mimicking the zonal architecture and composition of osteochondral
tissue, a lyophilization bonding process was developed. The process involves the joining of
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two unidirectionally-aligned freeze cast scaffolds (herein referred to as superficial zonemimicking scaffolds and lamellar osseous zone scaffolds) with an intermediate transition zone
suspension, where the entire assembly is lyophilized (Figure 3.1). The resulting product is a
fully integrated material fabricated from three independent material compositions.

Figure 3.1: Illustration of the lyophilization bonding process used to fabricate multidirectional
osteochondral scaffolds. An intermediate transition zone suspension was inserted below a
lamellar osseous zone scaffold and atop a superficial zone-mimicking scaffold, then lyophilized
to yield monolithic multidirectional scaffolds containing superficial (SZ), transition (TZ), calcified
cartilage (CCZ) and osseous zones (OZ).

To fabricate the superficial zone-mimicking scaffold, a suspension of type I collagen and
hyaluronic acid (hyaluronic acid sodium salt from Streptococcus equi, Sigma) was
unidirectionally freeze cast. Acid-soluble type I collagen derived from rat tail tendon was first
isolated in house according to Rajan et al.[110] and lyophilized. Collagen was then mixed with
hyaluronic acid at a ratio of 9:1 (wt/wt) in sterile deionized water to form a suspension totaling
2% (wt/vol). The suspension was homogenized with a rotor-stator homogenizer (Omni TH,
Omni-Inc) over ice for 10 minutes, degassed by centrifugation, and loaded into custom-made
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rectangular poly(methylmethacrylate) (PMMA) molds (inner dimensions: 7 mm x 7 mm x 29 mm
with a 5.5 mm wall thickness) (Figure 3.1B). PMMA molds were designed to promote a
unidirectional temperature gradient along their length via thermally conductive copper base
caps and insulative PMMA walls. Up to five molds were placed atop five copper cold fingers in
a custom made cooling bath containing an outer chamber of liquid N2 with sub-chambers of
absolute ethanol in contact with cold fingers (Figure 3.1A). Micah insulated electrical heating
jackets (OMEGA Engineering, INC) were wrapped around the tops of cold fingers to provide
cooling rates of 2ºC/min from 4ºC to -80ºC in conjunction with T-type thermocouples and a
temperature controller box containing 5 PID controllers (DTB4824, Delta Electronics). Freeze
cast constructs were then transferred to a lyophilizer (Freezone 6, LABCONCO) and freeze
dried under a vacuum of 0.03 mBar at -25ºC for ≥ three days.

Lamellar osseous zone scaffolds were fabricated by the co-precipitation of collagen and HA,
followed by self-compression and unidirectional freezing of the composite gel.[85] Briefly, type
I collagen dissolved in 0.02 M acetic acid was added to a 3X simulated body fluid solution
(containing 92 mM NaCl, 3.1 mM K2HPO4´3H2O, 3.3 mM MgCl2, 50 mM HEPES, 8 mM CaCl2,
and 17.5 mM NaHCO3) to a final concentration of 2.25 mg/mL. The solution was then titrated to
neutral pH with dropwise additions 1 N NaOH over ice, aged for 1 hr at room temperature, and
incubated at 37ºC overnight. The resulting gel was subject to 15 minutes of unconfined selfcompression, radially frozen between Styrofoam discs at -25ºC (Figure 3.1D), and lyophilized
for one week at -25ºC at 0.03 mBar. This combination of self-compression and radial freezing
creates a unique multilevel lamellar collagen-HA scaffold that serve as the osseous zone.[85]
To enhance structural stability during lyophilization bonding, lamellar osseous zone scaffolds
were crosslinked using 1% (wt/vol) 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
hydrochloride with 0.25% (wt/vol) N-hydroxysuccinimide in 2-(N-morpholino)ethanesulfonic
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acid buffer at a pH of 5 for 4 hr at room temperature, rinsed with 5% (wt/vol) glycine overnight,
rinsed thrice with sterile deionized water, and lyophilized under the previous conditions until
subsequent use.

Figure 3.2: Equipment and processes used to fabricate superficial zone and lamellar osseous
zone scaffolds: (A) custom-made cooling bath designed for unidirectional freeze casting of
superficial zone-mimicking scaffolds; (B) longitudinal and (C) isometric views of PMMA molds
for casting; (D) compressed collagen-HA gel sandwiched between thermally insulating
Styrofoam disks for radial freezing to produce lamellar osseous zone scaffolds.

For lyophilization bonding, a collagen-hyaluronic acid suspension was created to mimic the
composition and structure of the transition zone. A suspension of type I collagen and
hyaluronic acid was prepared at an 8:2 (wt/wt) ratio, respectively, to give a final concentration
of 1.5% (wt/vol) (unless stated otherwise) in sterile deionized water. The suspension was
homogenized over ice and degassed under centrifugation. Superficial zone-mimicking
scaffolds were cut to 5 mm3 with a thin layer shaved off of one face with a razor blade to
remove the non-porous skin. A 75 µL volume of degassed transition zone suspension was
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layered atop the cut superficial zone-mimicking scaffold face. One lamellar osseous zone
scaffold (cut to 4 mm3) was carefully placed into the intermediate suspension by approximately
0.5 mm, and the whole construct was frozen at -15ºC overnight then lyophilized at -25ºC under
a vacuum of 0.03 mBar for ≥ 3 days. Multidirectional scaffolds were then crosslinked using 1%
(wt/vol) EDC with 0.25% NHS in 95% ethanol for 4 hr at room temperature, rinsed with 5%
glycine overnight, rinsed thrice with sterile deionized water, and lyophilized under previous
conditions until further characterization.

3.2.2 Scanning electron microscopy
Longitudinal sections of multidirectional scaffolds were made by sectioning with a razor blade,
then sputter coated with Au-Pd (Polaron E5100, Quorum Technologies) for 1 min, and imaged
under field emission scanning electron microcopy (FESEM) (JSM- 6335F, JEOL) with an
accelerating voltage of 5 kV. Low magnification (25X) images were stitched together using the
MosaicJ plug in for ImageJ.[111] Elemental mapping (EDAX) for Ca and P was performed at the
insertion point of the lamellar osseous zone scaffold into the transition zone.

3.2.3 3D X-ray tomography
3D X-ray tomography (MicroXCT-400, Xradia) was performed on multidirectional scaffolds to
attain a three dimensional architectural data set. Crosslinked scaffolds were soaked in 1%
(wt/vol) iodine in absolute ethanol overnight to enhance radiopacity,[112] rinsed thrice with
deionized water, and lyophilized under previous conditions until imaging. Two thousand
images were acquired within an angle range of -95º to 95º, voltage of 20 kV, source power of 4
W, exposure time of 5 s, and 10X objective.
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For quantification of architectural properties, z-stack tomography images were segregated into
each of the four zones, imported into ImageJ, and binarized. Zonal pore size was quantified
using the mean linear intercept method where 4 line region of interests (ROIs) were made at
different orientations for 20 images. The Volume Fraction and Anisotropy tools within the
BoneJ[113] plugin suite for ImageJ were used to determine zonal porosity and anisotropy,
respectively. Zonal interconnectivity (interconnected void volume / total void volume) was
determined using the Volume Fraction and 3D Objects Counter,[114] where a sphere-filling
algorithm (Thickness, BoneJ) was applied to close pores ≤ 15 µm, as pores of this size do not
significantly contribute to mass transport.[91]

3.2.4 Confocal mapping of zonal hyaluronic acid
To confirm zone-specific hyaluronic acid retention, fluorescein isothiocyanate (FITC) was
conjugated to hyaluronic acid following the methods of de Belder and Wik.[115] FITC conjugation
was confirmed through Fourier transform infrared spectroscopy using the attenuated total
reflectance mode (ATR-FTIR) (Magna 560, Nicolet) (data not shown). Superficial zonemimicking scaffolds and transition zone suspensions were prepared with the FITC-hyaluronic
acid material, lyophilization bonded using the 2% (wt/vol) transition zone suspension, freeze
dried under the previous conditions, and crosslinked as before. The scaffolds were then
lyophilized under previous conditions a second time, sectioned longitudinally with a razor
blade, and viewed under confocal laser scanning microscopy (CLSM) (Nikon A1R, Nikon
Instruments, Inc.). Using ImageJ, zonal pixel intensity was calculated from an average of 15
circular ROI’s (35 pixels in diameter) drawn randomly in each zone.

3.2.5 Zonal compositional analysis
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ATR-FTIR spectroscopy (Magna 560, Nicolet) was performed on superficial, transition, calcified
cartilage, and osseous zone sections obtained from monolithic multidirectional scaffolds to
confirm zone-specific chemistry. Stock collagen, hyaluronic acid, and HA obtained from a
Proteinase-K digest of lamellar osseous zone scaffolds were examined for reference spectra.
Briefly, organic material was digested through Proteinase-K (Sigma) digestion at a
concentration of 0.33 mg/mL in TE buffer overnight at 55ºC. The HA sediment was collected,
rinsed thrice with deionized water, and lyophilized under previous conditions. Spectra were
collected over a range of 400 – 1750 cm-1 and scanned 16 times.

Lamellar osseous zone HA was characterized by thermogravimetric analysis (TGA) (TGA Q500, TA Instruments) and X-ray diffraction (XRD) (D2 Phaser, Bruker). For TGA analysis of HA
content, crosslinked lamellar osseous zone scaffolds were heated to 900ºC at 10ºC/min under
a N2 atmosphere. The water content was not considered in calculation of the total HA in the
scaffold. For XRD analysis, both lamellar osseous zone scaffolds and HA obtained from a
Proteinase-K digest were scanned from 10º to 70º at a step size of 0.02º.

3.2.6 Zonal compressive testing
Individual scaffold zones were fabricated, cut to an average diameter and thickness of 3.5 mm
and 3 mm, respectively, and hydrated in 1X phosphate buffered saline (PBS) at room
temperature for ≥ 1 hr prior to mechanical testing. Zonal scaffolds (n ≥ 5 / zone) were subject
to unconfined compression while immersed in PBS using a dynamic mechanical analyzer
(DMA) (DMA 2980, TA Instruments) with a 0.003 N preload and loaded to a maximum of 18 N
at 0.03 N / min. All zonal scaffolds were compressed along their native axes as in
multidirectional scaffolds (e.g. superficial zone-mimicking scaffolds compressed perpendicular
to fibers). From the resulting stress-strain curves, the compressive modulus (E*) was calculated
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from linear regression of the linear elastic region, the collapse modulus (∆s∆e) was determined
from linear regression of the collapse plateau, and the elastic compressive strength (s*el) was
determined as the stress at the junction of these two lines.[116]

3.2.7 Statistical analysis
One-way ANOVA with a post-hoc Tukey test was used to determine significant difference
between three or more groups. Statistical significance was accepted at p < 0.05 (*) or p <
0.005 (**). Statistical analyses were performed in Minitab 16 software (Microsoft).

3.3 Results
3.3.1 FESEM of multidirectional osteochondral scaffolds
To fabricate scaffolds mimicking both the zonal architecture and composition of osteochondral
tissue, a lyophilization bonding process was developed (Figure 3.1). This process, which
involved the joining of superficial zone-mimicking and lamellar osseous zone scaffolds with an
intermediate transition zone suspension, yielded monolithic multidirectional scaffolds with four
morphologically distinct zones (Figure 3.3A) and a mineral boundary (Figure 3.3B). Higher
magnification of scaffold zones displayed a thin, 0.125 mm thick region of compressed, highly
aligned collagen-hyaluronic acid fibers, constituting the superficial zone of the scaffold (A2).
The superficial zone was seamlessly interfaced (A6) with a 1.4 mm thick transition zone region
of isotropic pores (A3). The depth of lamellar osseous zone scaffold insertion into the transition
zone suspension created the calcified cartilage zone, approximately 0.6 mm thick, with a
combination of calcified cartilage zone and osseous zone scaffold morphologies (A4). Beyond
this zone, the osseous zone persisted, consisting of vertically-aligned sheets of mineralized
collagen fibers (A5) with a multilevel lamellar microstructure at a higher magnification (A7, white
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arrows). Elemental mapping of the insertion point of the osseous zone into the transition zone
(B1) revealed a boundary of both P (B2) and Ca (B3), localized to the CCZ and OZ.

Figure 3.3: (A) FESEM micrographs of multidirectional scaffold microstructure and (B)
elemental mapping of P and Ca at the osseous zone-transition zone insertion point. (A1)
Stitched FESEM micrograph of longitudinal section of multidirectional scaffold is presented,
where dotted white lines delineate zonal boundaries. (A2-A7) Higher magnification micrographs
highlight the zonal fiber architecture of the superficial zone (SZ, A2), transition zone (TZ, A3),
calcified cartilage zone (CCZ, A4), osseous zone (OZ, A5), superficial zone-transition zone
interface (A6), and the hierarchical structure of the osseous zone (A7). The dotted white line in
A6 outlines the superficial zone-transition zone interface. The white arrows in A4 highlight the
edges of osseous zone lamellae. The white arrows in A7 denote edges of constituent collagenHA lamellae. (B) Elemental mapping of P (B2) and Ca (B3) at the osseous zone-transition zone
interface, respectively, with reference to FESEM micrograph (B1).
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3.3.2 3D X-ray tomography of multidirectional scaffolds
To quantify zonal architectural properties, multidirectional scaffolds were analyzed by 3D X-ray
tomography (Figure 3.4). X-ray tomography highlights the 3D interconnected pore architecture
of the multidirectional scaffold (Figure 3.4A), displaying a highly aligned superficial zone
integrated with an isotropic transition zone. The transition zone infiltrates some depth into the
osseous zone, constituting the calcified cartilage zone, which leads to the lamellar osseous
zone. A 3D reconstruction of constituent scaffold zones is shown in Figure 3.4B-E, and
corroborate the FESEM data (Figure 3.3).

Figure 3.4: 3D X-ray tomography of multidirectional scaffolds. (A) 3D reconstruction of
multidirectional scaffold. (B-E) 3D reconstructions of the superficial (SZ, B), transition (TZ, C),
calcified cartilage (CCZ, D), and osseous zone (OZ, E). (F-I) Representative 2D z-stack images
of superficial (F), transition (G), calcified cartilage (H), and osseous zones (I) used for
quantification of architectural properties. White arrows in F highlight local dense regions of the
superficial zone.
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Quantification of zonal architectural properties (Table 3.1) was performed on zonal 3D
reconstructions (Figure 3.4B-E) from 2D z-stack images (Figure 3.4F-I) using ImageJ.
Table 3.1: Zonal architectural parameters

SZ

Pore Size or
Interlamellar Spacing (*) (µm)
48 ± 5

TZ

105 ± 16

89

99

0.18

CCZ

88 ± 16*

92

66

0.8

OZ

98 ± 15*

92

71

0.84

Zone

Porosity (%)

Interconnectivity (%)

Degree of Anisotropy

75

92

0.72

As expected, the superficial zone had the smallest mean pore size (48 µm) and the lowest
porosity (75%) of all four zones. In contrast, the transition possessed the largest pore size (105
µm) of all three zones, with a slight drop off in the calcified cartilage zone (88 µm) and osseous
zone (98 µm). Scaffold interconnectivity was high (≥ 92 %) for the superficial and transition
zones, but markedly lower for the calcified cartilage (66%) and osseous zones (71%). Zonal
collagen fiber morphology was quantified from 0-1, where 1 represents maximum anisotropy.
High structural anisotropy was calculated in superficial (0.72), calcified cartilage (0.8), and
osseous zones (0.84), but minimal in the transition zone (0.18).

3.3.4 Confocal imaging of zonal hyaluronic acid
To confirm zone-specific hyaluronic acid retention, confocal laser scanning microscopy (CLSM)
was performed on longitudinal sections of multidirectional scaffolds prepared with FITCconjugated hyaluronic acid (Figure 3.5). Fluorescence imaging (Figure 3.5A) revealed moderate
FITC-hyaluronic acid signal in the superficial zone, intense signal in the transition zone, a
gradient drop in the calcified cartilage zone, and negligible in the osseous zone. Quantification
of signal intensity (Figure 3.5B) displayed significant differences in FITC-hyaluronic acid signal

44

intensity in all zones. Notably, approximately twice the FITC-hyaluronic acid signal (34) was
present in the transition zone compared to the superficial zone (17.7), reflecting the amount of
hyaluronic acid loaded. A drop of 7.9 was calculated for the calcified cartilage zone, with
negligible signal (1.3) in the osseous zone.

Figure 3.5: (A) CLSM of FITC-conjugated hyaluronic acid in a longitudinal multidirectional
scaffold section, delineated into superficial (SZ), transition (TZ), calcified cartilage (CCZ), and
osseous (OZ) zones. (B) Quantification of zonal FITC-hyaluronic acid signal intensity. Statistical
significance at p < 0.05 is represented by *.

3.3.5 Zonal compositional analysis
Compositional analysis was performed on multidirectional scaffolds to ascertain zonal
chemistry and characterize osseous zone HA (Figure 3.6). ATR-FTIR spectra of constituent
scaffold zones (Figure 3.6A, top panel) revealed similar spectra across all zones, containing
Amide I and II peaks (1630 cm-1 and 1540 cm-1, respectively), ester bands (970 to 1300 cm-1)
and out-of-plane primary amine deformation (620 cm-1).[81,117] To deconvolute these spectra,
ATR-FTIR spectroscopy was performed on constituent HA, hyaluronic acid, and collagen
materials. Amide I and II peaks were contributed from the collagen. Phosphate stretching of HA
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overlapped with C-O stretching at 1030 cm-1, yielding a peak for all spectra. The presence of
carbonate was identified from the peak at 875 cm-1, identifying carbonated HA. Two modes of
phosphate stretching (P-O(v3), 600 cm-1 and P-O(v4), 560 cm-1) were observed in the HA
spectra and contributed to the broad shoulder in both calcified cartilage and osseous zone
spectra.

TGA of osseous zone scaffolds (Figure 3.6B) identified 25.6% (wt/wt) of HA in the materials.
The first weight loss occurred from the loss of water from the material, while the second
occurred from the burning off of organic material (collagen). The remaining plateau indicated
the amount of HA left in the composite.

XRD analysis of osseous zone scaffolds (Figure 3.6C) displayed three broad peaks due to
amorphous scattering from collagen. Upon removal of the collagen through a Proteinase-K
digest, the HA revealed six characteristic peaks at 26º ((002) plane), 32º ((overlap of (211),
(112), and (300) planes), 40º ((130) plane), 47º ((222) plane), 50º ((213) plane), and 53º ((004)
plane).
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Figure 3.6: Compositional analysis of multidirectional scaffolds. (A) ATR-FTIR spectra of
scaffold zones (superficial (SZ), transition (TZ), calcified cartilage (CCZ), and osseous zones
(OZ), top panel) and constituent materials (HA, hyaluronic acid (HYA), and collagen (COL),
bottom panel). Vertical dotted lines compare notable peaks across the spectra. The carbonate
peak in the HA spectrum is denoted by *. (B) TGA profile of osseous zone scaffolds with
FESEM micrograph insert of osseous zone HA. (C) XRD spectrum of osseous zone HA
obtained from a Proteinase-K digest of lamellar OZ scaffold (blue) with reference spectrum of
non-digested lamellar osseous zone scaffold (black). Dotted lines indicate notable peaks and
corresponding angles.

3.3.6 Zonal compressive mechanical properties
Constituent zones from multidirectional scaffolds were obtained and compressed in a hydrated
environment to assess zone-specific elastic modulus (E*), elastic compressive strength (s*el),
and collapse plateau modulus (∆s∆e) (Figure 3.7). From resultant stress-stain curves (Figure
3.7A), zonal E* were calculated from linear regression of the linear elastic region of the curves.
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Superficial, transition, calcified cartilage, and osseous zone scaffolds had elastic moduli of 7.2
kPa, 12.7 kPa, 13.9 kPa, and 17.0 kPa, respectively (Figure 3.7B). Transition, calcified, and
osseous zone scaffolds had statistically greater moduli compared to that of the superficial zone
scaffold. Additionally, calcified and osseous zone scaffolds displayed significantly higher
elastic compressive strengths (1.4 kPa and 1.2 kPa, respectively), compared to superficial and
transition zone scaffolds (0.2 kPa and 0.4 kPa, respectively) (Figure 3.7C). Lastly, ∆s∆e (slope
of the collapse region of stress-stain curves) were calculated for all zones (Figure 3.7D). Both
transition and calcified cartilage zone scaffolds had significantly higher values for ∆s∆e (3.5
kPa and 2.7 kPa, respectively) compared to superficial and osseous zone scaffolds (0.9 kPa
and 0.7 kPa, respectively).

Figure 3.7: Compressive testing of hydrated zonal scaffolds. (A) Stress-strain curves for
superficial (SZ), transition (TZ), calcified cartilage (CCZ), and osseous zone (OZ) scaffolds. (B)
elastic modulus (E*), (C) elastic compressive strength (s*el), and (D) collapse plateau modulus
(∆s∆e) for scaffold zones. Statistical significance at p < 0.05 is denoted by *.
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3.4 Discussion
The success of osteochondral tissue engineering has been mired by the difficulty of
engineering stable hyaline-like cartilage tissue. Fortunately, this challenge may be mitigated by
understanding the relationship between the zonal microstructure and bulk tissue function. Both
the arcade-like architecture of the collagenous network and graded glycosaminoglycan content
play a major role in conferring function to osteochondral tissue by dictating both the phenotype
of embedded chondrocytes and mechanical properties of each zone.[7,47,118] Without the
appropriate structural and compositional cues, regenerated tissue will lack zonal properties
and have comprised function; it is critical to impart zonal character in engineered
osteochondral tissue.

To accomplish this, unidirectional freeze casting combined with a lyophilization bonding
process was used to engineer collagen-based scaffolds that recapitulate the zonal
composition and architecture of the osteochondral unit. These scaffolds may serve as
biodegradable templates that guide the formation of zonal tissue through contact guidance of
infiltrated cells and physical confinement of newly-synthesized matrix.[119,120] Furthermore, the
presence of zone-specific compositional cues (i.e. hyaluronic acid or HA) in multidirectional
scaffolds may drive infiltrated progenitor cells down the appropriate lineage.[81,121]

Lyophilization bonding allowed for the fabrication of monolithic multidirectional scaffolds that
closely mimic the orientation and composition of the superficial, transition, calcified cartilage,
and osseous zones of osteochondral tissue (Figures 3.3 and 3.4). The layering of a small
volume (75 µL) of an intermediate suspension of collagen-hyaluronic acid served as a binder
that joined the underlying superficial zone-mimicking scaffold and overlying lamellar osseous
zone scaffold upon lyophilization. Integration between these materials was achieved through
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the infiltration and entanglement of the collagen-hyaluronic acid fibers with the surrounding
scaffolds (Figure 3.3, A4 and A6). The pores of the superficial and transition zones were highly
interconnected (92% and 99%, respectively, Table 3.1), suggesting their ability to efficiently
facilitate nutrient transport and cell migration. As expected, the calcified cartilage and osseous
zones exhibited markedly lower interconnectivity (66% and 71%, respectively), due to the
closed-channel structure formed by the collagen-HA lamellae. Despite the low calculated
values, pore channels are highly interconnected along their length, but are blocked by
collagen-HA sheets in the perpendicular direction (Figure 3.4, D and E), which contributes to
the lessened values. The high interconnectivity and low tortuosity along pore channels is
conducive for nutrient perfusion and directed cell growth and has been shown to guide earlier
bone formation than a collagen-HA scaffold with a tortuous, cellular pore structure.[120]

Each zone was designed to provide specific architectural cues for engineering zonal
osteochondral tissue. The superficial zone was formed from the local compression of the wet
superficial zone-mimicking scaffold surface under the load of the intermediate transition zone
suspension, yielding a thin layer (125 µm) of aligned collagen-hyaluronic acid fibers (degree of
anisotropy of 0.72) (Figure 3.3, A2). This zone constitutes the smallest zone of the
multidirectional scaffold, and approximates the thickness (200 µm) of the superficial zone in
human cartilage.[7] The superficial zone exhibited the lowest porosity (75%) of all zones, likely a
product of the compression of the collagen-hyaluronic acid fibers which created local areas of
dense matrix (Figure 3.4F, white arrows). This lower porosity may reduce local oxygen tension
by limiting gas diffusion, which has been shown to be in favor of cartilage from MSCs that is
not prone to mineralize.[122,123] Furthermore, the smaller elongated pore channels (48 µm, Figure
3.3, A2) may encourage infiltrating MSCs to adopt an elongated morphology which may help
establish a superficial zone phenotype.[47,124]
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The isotropic transition zone (Fig. 5, A3) formed from the homogenous freezing of the
intermediate transition zone suspension. This zone exhibited a cellular pore morphology with a
low degree of anisotropy (0.18) that emulates the random architecture of the native transition
zone. The cellular pore structure was conferred from the homogenous freezing of the transition
suspension, while the relatively high set freezing temperature of -15ºC was chosen to promote
the formation of larger pores (105 µm). This pore size is suitable to support the chondrogenesis
of MSCs; similar lyophilized isotropic collagen-hyaluronic acid scaffolds with a mean pore size
of 94 µm were found to promote early-stage chondrogenesis of MSCs in vitro.[81] Furthermore,
the combination of this isotropic morphology with negatively-charged carboxyl groups of
hyaluronic acid may promote a desired spherical morphology of seeded cells, akin to that of
transition zone chondrocytes.[53] The cytoskeletal arrangement in round MSCs upregulates
chondrogenic gene expression by altering the interaction of cells with TGF-B3, decreasing Ncadherin and Rac1 activity.[125]

A tidemark-like mineral boundary (Figure 3.3B) separated the transition zone from the calcified
cartilage zone, where the latter is formed from the infiltration of the transition zone suspension
into the lamellar osseous zone scaffold (Figure 3.3, A4). This zone mimics the structure of the
native calcified cartilage zone, consisting of vertically-oriented mineralized collagen and the
subchondral bone (osseous zone).[8,47] A slightly lower degree of anisotropy (0.8) was present
compared to the osseous zone (0.84), which can be attributed to the infiltrated isotropic
transition zone. Together, this interface of vertical osteogenic osseous zone lamellae of suitable
interlamellar spacing (88 µm) with infiltrated chondrogenic collagen-hyaluronic acid material
may encourage MSCs to adopt a hypertrophic chondrocyte phenotype.[15,47]
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The remaining lamellar osseous scaffold forms the osseous zone (Figure 3.3, A5). This zone
displayed the highest degree of anisotropy (0.84) of all zones, with a mean interlamellar
spacing of 98 µm. Through the compression and subsequent lyophilization of collagen-HA
hydrogel, a unique multi-lamellar architecture was produced, which consists of highly aligned
lamellae of collagen-HA at the macroscale, formed from the radial freezing of the hydrogel. At
the microscale, each lamellae consists of smaller aligned micro-lamellae (Figure 3.3, A7)
themselves consisting of a meshwork of mineralized collagen fiber bundles at the nanoscale.
These scaffolds have been extensively characterized and shown to be osteogenic and induce
the differentiation of BMSCs in a rat calvarial defect model in our previous work.[85,120,126,127]

In addition to the zonal architectural cues, multidirectional scaffolds contained a graded
chemical composition to mimic that in the osteochondral unit. CLSM verified significantly
different concentrations of hyaluronic acid for each zone (Figure 3.5). Notably, twice the
amount of hyaluronic acid was detected in the transition zone compared to that in the
superficial zone, reflecting the amount of hyaluronic acid initially loaded. This increase of
hyaluronic acid from the superficial to transition zone coincided with a decrease in collagen,
mimicking the opposing gradients of these macromolecules in native osteochondral tissue.
Zone-specific chemical composition was identified with ATR-FTIR spectroscopy (Figure 3.6A).
While the spectra of all zones were similar, the presence of phosphate from HA in the osseous
zone led to greater intensity of the low IR shoulder (700-400 cm-1) relative to the Amide I band
compared to superficial, transition, and calcified cartilage zones. Furthermore, the presence of
additional hyaluronic acid in the transition zone compared to the superficial was noted from the
increase in ester band intensity relative to the Amide I band. Osseous zone HA was identified
as carbonated, amorphous HA (Figure 3.6A, C), similar to HA in natural bone. The amount (26
wt%, Figure 3.6B), though lower than that in native bone (50-70 wt%), was shown to be
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osteoconductive and induce bone formation in mouse calvarial defects within 4 weeks when
loaded with bone marrow stromal cells.[11,128]

All scaffold zones were characterized for their hydrated compressive mechanical properties
(Figure 3.7). All zones exhibited mechanical behavior typical of cellular solids in compression:
an initial linear elastic regime as pore struts elastically bend, strut buckling manifested as a
collapse plateau, and strut densification resulting in an exponential increase in stress with
increasing strain (Figure 3.7A).[116] There was an increase in E* throughout the depth of
multidirectional scaffolds, but the differences were not significant (Figure 3.7B). There was,
however, a significant difference in E* between the superficial zone and other zones. The
smaller value for the superficial zone can be attributed to both the perpendicular arrangement
of scaffold fibers relative to the applied load, as well as decreased content of hyaluronic acid
compared to the transition zone. Hyaluronic acid has been suggested to contribute to
increased moduli of collagen scaffolds by conferring extra crosslinking sites from its abundant
carboxyl groups.[129] While the moduli of the zones are drastically lower than those of human
articular cartilage (0.3-1.5 MPa)[130] and bone (12-20 GPa),[131] they are at or near values reported
for matrices conducive for chondrogenesis or osteogenesis of MSCs.[132–135] The stiffness
values achieved for the chondral zones (7.18 – 13.88 kPa) approximate a range found suitable
for supporting chondrogenesis of MSCs (5.4-11.8 kPa).[135] Moreover, the increase of modulus
with depth may induce stiffness-depended changes in cell morphology, yielding more hyaline
cartilage in the compliant superficial zone and fibrous cartilage in the calcified cartilage
zone.[135] The modulus for the osseous zone (16.95 kPa) is slightly below the target modulus for
osteogenesis (25-40 kPa).[134] In future work, this stiffness can be enhanced by increasing the
HA content of lamellar osseous zone scaffolds during the co-precipitation process. The
presence of the vertically oriented collagen-HA lamellae from the osseous zone scaffold likely
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contributed to the significant increase in compressive strength of the calcified cartilage and
osseous zones over the superficial and transition zones by nearly an order of magnitude
(Figure 3.7C). As a monolithic scaffold, it is ideal that the bottom two zones display the highest
strength values, as they may act to support the construct during bulk compression. This
recapitulates the mechanical roles of the calcified cartilage and osseous zones of
osteochondral tissue, resisting maximum deformation under compression.[47] Lastly, ∆s∆e
(modulus of collapsing struts) values were calculated for all scaffold zones to identify the pore
wall buckling mechanics of each zone (Figure 3.7D).[116,129] The transition and calcified cartilage
zones displayed significantly higher collapse moduli than superficial and osseous zones.
Unsurprisingly, the presence of isotropic collagen-hyaluronic acid fibers lent the greatest
resistance to pore buckling; the equiaxed pore structure may help evenly distribute the
compressive load across pore walls. Furthermore, the addition of these fibers in between
osseous lamellae in the calcified cartilage zone may integrate adjacent lamellae (Figure 3.4D,
H), preventing them from separating apart upon compression as they did in the osseous zone.

This work represents significant progress in the development of easy to manufacture, yet
sophisticated biomaterial technologies for the regenerative engineering of osteochondral
tissue. Clinically, the unique architecture of these multidirectional scaffolds holds potential in
augmenting microfracture surgery, where the exposed marrow population may infiltrate
through the bony lamellae of the osseous zone and be coerced to differentiate to the desired
zonal phenotype by the provided architectural and compositional cues. The ability of these
materials to do so with a single progenitor cell population will be investigated in forthcoming in
vitro and in vivo studies.
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3.5 Conclusions
Based on the facile platform of unidirectional freeze casting, monolithic scaffolds that
recapitulate the zonal structure and composition of osteochondral tissue were created.
Multidirectional osteochondral scaffolds were designed by a lyophilization bonding process
and closely mimic the zonal fiber orientation and composition of the superficial, transition,
calcified cartilage, and osseous zones of osteochondral tissue. The transition zone contained
twice the amount of hyaluronic acid than the superficial zone, mimicking the increase of
glycosaminoglycans with depth in native osteochondral tissue. Furthermore, the mechanical
properties of zones were quantified and deemed suitable for the zone-specific chondrogenesis
of MSCs, though the modulus of the osseous zone is slightly less than targeted. These
scaffolds with biomimetic zonal structure and composition hold great promise in engineering
new osteochondral tissue with zonal character.
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Chapter 4
In vitro and in vivo evaluation of osteochondral differentiation on zonal biomaterials via
observation of fluorescent multi-reporter cells

4.1 Introduction
Articular cartilage was once considered a relatively simple organ to engineer due to its
apparent structural and functional simplicity. However, attempts have proven exceptionally
difficult due to the tissue’s avascularity, complex zonal structure and composition, and
frequent association with subchondral bone injury.[2,3,8,108] The zonal character of osteochondral
tissue is critical to recapitulate in regenerated tissue as each zone bestows unique properties
to the bulk tissue, and is critical for long-term joint function. The apical superficial zone, for
example, consists of laterally-aligned, densely packed type 2 collagen fibers which provide
high resistance to shear force of the opposing arthrodial joint. Embedded cells in this zone
adopt a superficial zone phenotype, characterized by a flattened morphology and expression
of boundary lubricating molecule PRG4.[7,12] In light of the importance of zonal properties, the
development and use of biodegradable, anisotropic tissue engineering matrices that mimic the
structure and/or composition of osteochondral tissue have been gaining momentum.[41,46,52–54]

A recent notable advancement in biomaterial design is the production of collagen-based
multidirectional zonal (MZ) scaffolds that mimic both the fiber orientations and chemical
compositions of the superficial, transition, calcified cartilage, and osseous zones of
osteochondral tissue in monolithic unit, as reported by our laboratory.[136] A facile lyophilization
bonding approach is used to join a unidirectionally-aligned superficial zone-mimicking scaffold
(comprised of type 1 collagen and hyaluronic acid) with a lamellar osseous zone scaffold
(comprised of type 1 collagen mineralized with carbonated hydroxyapatite) using a medial
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transition zone suspension (comprised of type 1 collagen and hyaluronic acid) (Figure 4.1A).
Resulting matrices contain a 200 µm-thick laterally-organized superficial zone, an isotropic
transition zone, a calcified cartilage zone consisting of osseous zone lamellae interdigitating
the overlying transition zone, and a vertically-oriented osseous zone consisting of lamellae of
type 1 collagen mineralized with carbonated hydroxyapatite (Figure 4.1B). These matrices may
provide the necessary chondrogenic (hyaluronic acid) and osteogenic (carbonated
hydroxyapatite) chemical cues to promote the differentiation of chondrocytes and bone
marrow stromal cells (BMSCs) along chondrogenic and osteogenic lineages, respectively.
Further, the zone-specific matrix alignment may guide the formation of new tissue that is
aligned with the zonal pore structure of the material. Generated tissue may then recapitulate
the native zonal properties of osteochondral tissue.

To evaluate the ability of such biomaterials to support the differentiation of a given cell line,
destructive characterization modes (e.g. quantitative gene expression analysis, histological
staining, immunohistochemistry.) are often used. However, a need exists for a means to nondestructively monitor cell differentiation in real time. To address this need, we employ a novel
fluorescent reporter gene-approach to study cell differentiation on our MZ scaffolds. The Rowe
laboratory has developed various lines of transgenic mice harboring different combinations of
promoter-driven green fluorescent protein (GFP) reporters that activate at defined levels of cell
differentiation. This system has been combined with a cryohistological protocol that preserves
GFP expression and has been used to study various stages of osteoblastic differentiation in
vivo,[137,138] fracture repair,[139] changes in chondrocyte cell populations in response to load,[140,141]
and new progenitor cell populations through lineage tracing experiments.[142,143] To date,
however, this approach has seldom been applied to study cell differentiation on biomaterials in
vitro.
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The aim of this study is to investigate the ability of MZ scaffolds to support the differentiation of
fluorescent reporter murine chondrocytes and BMSCs along chondrogenic and osteogenic
lineages. For osteogenic differentiation, BMSCs derived from dual transgenic mice harboring
reporters for bone sialoprotein (BSP-GFPtopaz) and dentin matrix protein (DMP1-RFPmCherry)
will be used, where the progressive expression from BSP to DMP-1 (indicating pre-osteoblast
to mature osteoblast/osteocyte maturation) will be analyzed. For chondrogenesis, articular
chondrocytes from triple-transgenic mice (Col3.6-GFPtopaz, Col2a1-GFPcyan, Col10a1RFPmCherry) harboring reporters for different chondrogenic fates (Col3.6 – fibrochondrocytes,
Col2a1 – articular chondrocytes, Col10a1 – hypertrophic chondrocytes) will be used. Further,
gene expression and cryohistological analyses will be used to investigate the zone-specific
maturation of transgenic chondrocytes.

4.2 Materials and methods
4.2.1 Scaffold fabrication
Zonal multidirectional scaffolds were fabricated by a lyophilization-bonding procedure
previously published.12 Superficial zone mimicking and lamellar osseous zone scaffolds were
first prepared. The former were fabricated by the unidirectional solidification of an aqueous
suspension containing acid-soluble rat tail collagen (derived in-house according to Rajan et
al)[110] and hyaluronic acid (hyaluronic acid sodium salt from Streptococcus equi, Sigma) at a
9:1 wt/wt ratio of collagen:hyaluronic acid to total 2% (wt/vol). The suspension was
homogenized with a rotor-stator homogenizer (Omni TH, Omni-Inc) over ice, degassed by
centrifugation, unidirectionally frozen from 4ºC to -80ºC at 4ºC/min, and lyophilized at -25ºC
and 0.03 mBar for ≥3 days. Lamellar osseous zone scaffolds were fabricated by coprecipitation of collagen and hydroxyapatite at neutral pH in a modified simulated body fluid
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solution containing 92 mM NaCl, 3.1 mM K2HPO4 3 3H2O, 3.3 mM MgCl2, 50 mM HEPES, 8
mM CaCl2, 17.5 mM NaHCO3 and 2.25 mg/mL acid-soluble rat-tail collagen.[85,91,126] The
resulting gel was subject to 15 min of unconfined self-compression, followed by radial freezing
at -25ºC overnight, and lyophilized under the previous conditions. Lamellar osseous zone
scaffolds were then crosslinked with 1% (wt/vol) 1-ethyl-3–(3dimethylaminopropyl)carbodiimide hydrochloride (EDC) and 0.25% (wt/vol) Nhydroxysuccinimide (NHS) in 2-(N-morpholino)ethanesulfonic acid buffer at a pH of 5 for 4 h at
room temperature, rinsed with 5% (wt/vol) glycine overnight, rinsed thrice with sterile deionized
water, and lyophilized under the previous conditions. Zonal multidirectional scaffolds were
made by bonding underlying superficial zone mimicking scaffolds with overlying lamellar
osseous zone scaffolds using 75 µL of an intermediate aqueous suspension of collagenhyaluronic acid at an 8:2 ratio of collagen:hyaluronic acid to total 1.5% (wt/vol) (Figure 4.1A).
These constructs were then frozen at -25ºC, lyophilized under previous conditions, and
crosslinked with 1% (wt/vol) EDC containing 0.25% NHS in 95% ethanol for 4 hr at room
temperature, rinsed with 5% glycine overnight, rinsed thrice with sterile deionized water, and
lyophilized under the previous conditions.

Isotropic collagen-hyaluronic acid (ICH) and isotropic collagen (IC) scaffolds were fabricated to
serve as scaffold controls for anisotropy (ICH), and both anisotropy and hyaluronic acid (IC).
Aqueous suspensions of collagen-hyaluronic acid and collagen were prepared to total 1.5%
(wt/vol). ICH scaffolds contained collagen:hyaluronic acid at an 8:2 ratio. Prepared
suspensions were first homogenized over ice, degassed, isotropically frozen at -25ºC, and
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lyophilized for ≥ 3 days. Scaffolds were then crosslinked with 1% EDC:NHS in 95% ethanol as
before, then lyophilized ≥ 3 days.

Fig 4.1: (A) Illustration of multidirectional zonal scaffold fabrication, involving the simple joining
of a unidirectional superficial zone scaffold with an orthogonal lamellar osseous zone scaffold.
(B) Multidirectional zonal scaffold design, matching the superficial, transition, calcified
cartilage, and osseous zones with their occurrence in native osteochondral tissue. (C) In vitro
study design, where primary transgenic articular chondrocytes and BMSCs are expanded in
hypoxia, seeded on multiple scaffold types, and cultured in defined osteogenic or
chondrogenic media for 21 days. A characterization timeline is provided below. (D)
Subcutaneous implantation study. Triple-transgenic primary articular chondrocytes were
expanded to passage 1, cultured for 1 week in defined chondrogenic media, seeded on MZ or
not (unseeded control), then implanted in subcutaneous pockets on the backs of mice for 8
weeks. Tissue was then harvested and subject to hematoxylin and eosin, safranin o-fast green,
von Kossa, and Vector Blue (ALP) stains.
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4.2.2 Transgenic primary articular chondrocyte and BMSC culture
Primary BMSCs were obtained by harvesting bone marrow from 3-4 week-old dual transgenic
mice containing BSP-GFPtopaz and DMP1-RFPmCherry fluorescent reporter genes (Figure
4.1C). Hind legs were harvested and tibias and femurs were collected in cold, sterile 1X PBS.
Epiphyseal bone was cut and bone marrow was flushed with 10 mL sterile expansion media
using a 25 5/8-gauge syringe needle. Collected marrow was then passed through an 18 1/2–
gauge needle to break up tissue pieces, plated at 10 x 106 cells/well in a 6-well plate, and
cultured in hypoxic incubation (37ºC, 5% CO2, 5% CO2). Media was replenished after four days
of initial expansion to allow for hematopoietic cells to promote initial BMSC colony formation[91]
and to remove non-adherent non-stromal cells. Expansion media was replenished every other
day until confluency at passage 1.

Primary articular chondrocytes were harvested from 3-4 week-old triple transgenic mice
containing Col3.6-GFPtopaz, Col2a1-GFPcyan, and Col10a1-RFPmCherry fluorescent reporter
genes (Figure 4.1C). Following CO2 asphyxiation, hind legs were collected and placed in cold,
sterile 1X PBS. Femoral condylar cartilage was isolated with a scalpel and placed in a digestion
buffer containing 3 mg/mL collagenase D (Roche), 2 mg/mL dispase (GIBCO), and 1% (vol/vol)
penicillin-streptomycin (GIBCO) in sterile Hank’s Balanced Salt Solution (HBSS, GIBCO).
Tissue was digested for three 40 min cycles at 37ºC, with supernatant collected into sterile
expansion media (high glucose DMEM, GIBCO, containing 10% fetal bovine serum (FBS,
Hyclone) and 1% penicillin-streptomycin) over ice. Tissue supernatant was then sterile-filtered
over a 70 µm nylon membrane and plated at 65-80 x 106 viable cells per well in a 6-well tissue
culture-treated plate. Primary chondrocytes were expanded to confluency at passage 1 in
hypoxic incubation with expansion media replacement every other day.
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4.2.3 Scaffold seeding and in vitro culture
Zonal multidirectional scaffolds were cut to approximately 6 x 3 x 3 mm (0.054 cm3) and Healos
(a widely-used commercial apatite/collagen scaffold to serve as a positive control for
osteogenesis) (DePuy Spine), IC and ICH scaffolds were cut to approximately 4 x 2 x 2 mm
(0.016 cm3) with sterile razor blades. Care was taken to remove surface skin layers to create
open pore surfaces. All scaffolds were disinfected with 70% ethanol for 1 hour, then rinsed
with sterile 1X PBS thrice. Scaffolds were then soaked overnight in sterile DMEM at room
temperature to promote protein adsorption. The next day, soaked scaffolds were briefly dried
over sterile cloth to remove entrapped media, transferred to ultra-low attachment 24-well
plates, and seeded with either 4.5 x 106 cells/cm3 articular chondrocytes or 9 x 106 cells/cm3
BMSCs. Cells were allowed to attach in hypoxic incubation for 2 hours, with small media
additions as needed to keep samples hydrated. For articular chondrocytes, a full volume (1.5
mL) of defined chondrogenic media (high glucose DMEM supplemented with 1% ITS (GIBCO),
500 µg/mL BSA (Sigma), 4.7 µg/mL linoleic acid (Sigma), 1 x 10-4 M ascorbic acid (Sigma), 4 x
10-4 M proline (Sigma), 1% penicillin-streptomycin, 10 ng/mL hTGFb1 (R&D Systems, Inc.), and
10-7 M dexamethasone (Sigma)) was gently added. For BMSCs, 1.5 mL of defined osteogenic
media (aMEM (GIBCO) supplemented with 10% FBS, 1% penicillin-streptomycin, 8 mM bglycerophosphate (Sigma), and 50 µg/mL ascorbic acid) was added. For both groups, cellseeded constructs were cultured for 21 days in either hypoxia (chondrocytes) or normoxia
(20% O2, 5% CO2, 37ºC, BMSCs) with media replacement every other day. A positive control
for osteogenesis was created by culturing BMSCs in 6-well plates in DMEM, aMEM, and
defined osteogenic media. Verification of osteogenesis was performed at day 21 by fluorescent
imaging of reporter expression and von Kossa staining. A positive control for chondrogenesis
was made by creating a pellet culture of transgenic articular chondrocytes (0.25 x 106 cells
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pelleted in a 15 mL conical tube) and cultured in 1 mL of defined chondrogenic media for 21
days,[144] where reporter expression of the pellet was checked at day 21.

4.2.4 In situ fluorescence microscopy
At days 0 (pre-seeding, data not shown), 3, 7, 14, and 21 of culture, reporter cell fluorescence
(N=2) was captured using the Zeiss Axio Observer Z.1 inverted fluorescence microscope.
Fluorescence was captured by tiling images over the entire scaffold surface in ZEN software at
an objective of 5X. For osteogenic culture, exposure times of 100 ms and 500 ms were applied
for GFP (BSP-GFPtopaz) and RFP (DMP1-RFPmCherry) channels, respectively. For
chondrogenic culture, an exposure time of 100 ms was applied for GFP (Col3.6-GFPtopaz and
CFP (Col2a1-GFPcyan) channels, while 300 ms was applied for RFP (Col10a1-RFPmCherry).
Tiled images were then stitched together to create a mosaic. Fluorescence intensity of all
images were then normalized by adjusting the pixel intensity histogram so that the middle
slider was positioned to the right-base of the main intensity peak, exposing all present
fluorescent signal at equal intensity levels across images.

4.2.5 Fluorescence-activated cell sorting (FACS) analysis
At days 7, 14, and 21, cultured cells were harvested from scaffolds and subject to FACS
analysis. At a given time-point, scaffolds were digested in an enzyme buffer containing 2
mg/mL collagenase D (Roche), 2 mg/mL hyaluronidase (Sigma), 20% (vol/vol) 0.25% trypsinEDTA (GIBCO), and 10% pen-step in HBSS. Four sequential digestions were carried out at
37ºC while shaking for 30 min. After each cycle, the digest was collected into sterile expansion
media over ice. The digestion solution was then spun down and added to sterile 1X PBS
containing 2% FBS, filtered over a 70 µm nylon membrane, and re-suspended in 400 µL of
fresh 1X PBS with 2% FBS for FACS analysis. Cell suspensions were subject to FACS analysis
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(Becton-Dickinson FacsAria II) with a 130 μm nozzle equipped with lasers of 405 nm at 50 mW
for CFP, 488 nm at 100 mW for GFP, and 561 nm at 40 mW for RFP. At least 5,000 events of
ungated events were collected. Percentages of the fluorescent population were calculated by
normalizing GFP, RFP, or CFP positive events to the entire positive fluorescent events
population.

4.2.6 Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR)
At days 0, 7, and 21, mRNA from BMSCs and chondrocytes in superficial, transition/calcified
cartilage and osseous zones was extracted and subject to qRT-PCR. At a given time-point,
three (N=3) scaffolds were removed from culture and separated into superficial,
transition/calcified cartilage, and osseous scaffold zones under a stereo-microscope in a sterile
hood. Scaffold zones were homogenized in 500 µL of TRIzol reagent (Life Technologies) over
ice and frozen at -20ºC until RNA extraction. Zonal RNA was extracted by phase separation
using 20% (vol/vol) chloroform in TRIzol, followed by precipitation in isopropanol. The resulting
total RNA pellet was rinsed with 75% ethanol and dissolved in DNAse digestion solution (New
England Biolabs) to remove DNA contamination. The RNA was further purified by magnetic
bead separation (RNAClean XP, Beckman Coulter) on a MiniMACS (Miltenyi Biotec) magnetic
separator rack. The resulting nucleic acid yield was quantified using a Nanodrop 2000
Spectrophotometer (Thermo Fisher Scientific) with purity and concentration determined from
absorbance at 260 and 280 nm. 100 ng of total RNA was reverse-transcribed to cDNA using a
MultiScribe Reverse Transcriptase with random primers (Applied Biosystems). qRT-PCR was
performed on cDNA using the SYBR Green method (Bio-Rad). Forward and reverse primers
used are listed in Table I. Fold-change of osteogenic markers (RUNX2, osteocalcin (OCN),
alkaline phosphatase (ALP), bone sialoprotein (BSP), and dentin matrix protein (DMP-1)) and
chondrogenic markers (SOX9, aggrecan (AGG), type 1 collagen (COL1A1), type 2 collagen
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(COL2A1), and type 10 collagen (COL10A1)) relative to day 2 (osteogenic experiments) or day 0
(chondrogenic experiments) mRNA expression levels were calculated using the 2-∆∆CT
method, and are normalized to housekeeping gene GAPDH expression levels.

Table 4.1: Sequences of primers used for qRT-PCR.
Osteogenic and chondrogenic primers are in blue and red text, respectively.

Gene
GAPDH
RUNX2
OCN
ALP
BSP
DMP-1
SOX9
AGG
COL1A1
COL2A1
COL10A1

Forward primer
AGGTCGGTGTGAACGGATTTG
AGGTTCAACGATCTGAGATTT
GAGGACCATCTTTCTGCTCACTCT
GATCATTCCCACGTTTTCACATT
CGCCACACTTTCCACACTCTC
CGCATCCCAATATGAAGACTG
GAGCCGGATCTGAAGAGGGA
ACAACTGGCAGTGGGGAAAG
TGTGTTCCCTACTCAGCCGTC
TCGCACTTGCCAAGACCTGAA
GCTGCCTCAAATACCCTTTCTG

Reverse primer
TGTAGACCATGTAGTTGAGGTCA
GACTGTTATGGTCAAGGTGAA
TTATTGCCCTCCTGCTTGGA
TTCACCGTCCACCACCTTGT
CTTCCTCGTCGCTTTCCTTCAC
GCTTGACTTTCTTCTGATGACTCA
GCTTGACGTGTGGCTTGTTC
CCTCAGGGTAAGCAGACAGG
GCAGCCGTCCACAAGGGT
GGTCTCTCCAAACCAGATGTG
GGACCAGGAATGCCTTGTTCT

4.2.7 Cryohistology
At day 21, scaffold sections were fixed with 10% neutral-buffered formalin (Sigma) at 4ºC
overnight, rinsed with 1X PBS thrice, then soaked in 30% sucrose (Sigma) in deionized water
at 4ºC until samples became isotonic. Samples were then briefly patted dry and embedded in
Optimal Cutting Temperature Compound (Tissue-Tek) by submersion in 2-methylbutane chilled
with dry ice. Embedded samples were then cryosectioned to a thickness of 5 µm, adhered to
cryotape (Cryofilm type II, Section-Lab, Co), and UV-crosslinked onto glass slides. For BMSCseeded samples, sections were stained with hematoxylin and eosin for cell and tissue
morphology, Vector Blue (Vector Blue Alkaline Phosphatase Substrate, Vector Labs) for ALP
deposition, and von Kossa for phosphate mineral deposits. For chondrocyte-seeded samples,
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sections were stained with hematoxylin and eosin, Vector Blue, von Kossa, and safranin-o/fast
green for sulfated-proteoglycan deposition. Un-seeded scaffold sections were used as
negative controls to test for background staining (data not shown). Sections were mounted
with 30% glycerol in deionized water or 1X PBS and color imaged with a Zeiss Axio Scan Z.1
automatic fluorescent slide scanning microscope with a 10X objective.

4.2.8 Immunohistochemistry
Formalin-fixed chondrocyte-seeded scaffold sections from day 21 were subject to
immunohistochemistry for protein deposition of the following markers: type 1 collagen, type 2
collagen, type 10 collagen, and indian hedgehog homolog (Ihh). Tissue samples were first
imaged to collect background fluorescence, then heated in antigen retrieval solution (2 mg/mL
bovine serum albumin (BSA) in 1X PBS) for 10 min at 42ºC, rinsed in 1X PBS, placed in 0.1%
Triton X-100 in antigen retrieval solution for 10 min, rinsed in 1X PBS, rinsed in 1X Power
Blocking Reagent (Power Block Universal Blocking Reagent, BioGenex) for 20 min, rinsed with
1X PBS, then incubated with 1º antibody at 4ºC overnight at optimized dilutions in antigen
retrieval solution (goat polyclonal type 1 collagen, AB758, Millipore,1:100; mouse monoclonal
type 2 collagen, II-II6B3, Developmental Studies Hybridoma Bank, 1:10; rabbit polyclonal type
10 collagen, AB58632, ABCAM, 1:100; rabbit polyclonal anti-Ihh, AB39634, ABCAM, 1:200;
rabbit polyclonal anti-PRG4, NBP1-19048, Novus Biologicals,1:50). Sections were then rinsed
with 1X PBS, covered with 1:200 dilution of Alexa Fluor 488-conjugated 2º antibody for 1 hr at
room temperature (Alexa Fluor 488 goat anti-rabbit IgG, A11008, Thermo Fisher Scientific;
Alexa Fluor 488 donkey anti-goat IgG, A11055, Thermo Fisher Scientific; Alexa Fluor 488 goat
anti-mouse IgG, A11001, Thermo Fisher Scientific), rinsed with 1X PBS, then counterstained
with 0.1% Hoechst (Hoechst 33342, trihydrochloride, trihydrate, Molecular Probes) in 50%
glycerol in 1X PBS. To check for nonspecific 2º antibody binding on scaffold materials, MZ
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sections were labeled with each variant of the 2º antibody (data not shown). Antibody
fluorescence was imaged on a Zeiss Axio Scan Z.1 automatic fluorescent slide scanning
microscope with a 10X objective.

4.2.9 Subcutaneous implantation
Animal studies were conducted under approved protocols from the Institutional Animal Care
and Use Committee. MZ scaffolds with and without articular chondrocytes were implanted
subcutaneously in the backs of non-transgenic NSG mice for 8 weeks. First, zonal scaffolds
cut to 6 x 3 x 3 mm (0.54 cm3) were sterilized with ethylene oxide in a bench top oven (AN74i
Anprolene Sterilizer, Andersen Products) for 24 hours, then vented overnight to remove
residual ethylene oxide gas. Scaffolds were prepared for seeding as before (disinfected with
70% ethanol, soaked in expansion media), and seeded with 4.5 x 106 primary articular
transgenic chondrocytes (passage 1) carrying Col3.6-GFPtopaz, Col2a1-GFPcyan, and
Col10a1-RFPmCherry fluorescent reporter genes. Chondrocyte-seeded and unseeded (N=2
per group) scaffolds were cultured for one week in vitro in defined chondrogenic media prior to
implantation. For surgery, mice were administered a pre-operative intraperitoneal injection (5
µL/g of mouse) of ketamine and xylazine in 0.9% saline solution. Dorsal incisions 1 cm in
length were made, where scaffolds were inserted in pouches. Dorsal pouches were sutured
and mice were returned to their cages with a post-operative intraperitoneal injection (5 µL/g of
mouse) of meloxicam at 1 mg/mL. Meloxicam was also administered 24 hours following
surgery. After 8 weeks, mice were sacrificed, and tissue was perfusion-fixed with 10% NBF for
histological analysis. Tissue was then subject to hematoxylin and eosin, safranin-o/fast green,
Vector Blue, and von Kossa stains.
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4.2.10 Statistical analysis
Statistical difference between three or more groups was calculated using a one-way ANOVA
with a post-hoc Tukey test. Difference between two groups was calculated using a Student’s ttest. Statistical significance was accepted at p < 0.05 (*). Analyses were performed in Minitab
16 software (Microsoft).

4.3 Results
4.3.1 BMSC osteogenesis
4.3.1.1 In situ fluorescence microscopy
Primary BMSCs carrying the fluorescent reporter combination BSP-GFPtopaz x DMP1RFPmCherry were seeded atop both MZ and Healos scaffolds and cultured in osteogenic
conditions for 21 days, where reporter fluorescence was evaluated in real-time at days 3, 7, 14,
and 21 of culture. Healos, a commercially available collagen-hydroxyapatite scaffold (20 wt.%
HA/80 wt.% type I collagen), was included for a positive scaffold control for osteogenesis.
Reporter fluorescence is represented as intensity-adjusted data (Figure 4.2A and 4.2B), which
permits evaluation of all total fluorescence at each time point, and raw fluorescence data
(Figure 4.3), which allows visualization of temporal changes in reporter activity (intensity).
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Figure 4.2: Intensity-normalized fluorescence of BSP-GFPtopaz (A) and DMP1-RFPmCherry (B)
in transgenic BMSCs seeded atop MZ (a-d) and Healos (e-h) scaffolds at days 3 (a,e), 7 (b,f),
14 (c,g), and 21 (d,h) of osteogenic culture. Dotted squares highlight higher-magnification
regions shown in corner insets. (C) FACS analysis for BMSC osteogenesis on MZ and H
scaffolds. Positive fluorescent percentage for specified fluorescence (GFP, RFP, GFP+RFP)
from overall fluorescent cell populations are shown. Data are represented in terms of day (top)
and scaffold (bottom).

69

For both scaffolds, BSP-GFPtopaz fluorescence was present in few cells at Day 3 (Figure 4.2A,
a and e), but significantly increased up to day 21 (Figure 4.2A, d and h). DMP1-RFPmCherry
fluorescence was evident in just a few cells at day 3 for both materials (Figure 4.2B, a and e),
but became more prevalent at day 7 (Figure 4.2B, b and f). Like BSP-GFPtopaz, the amount of
cells expressing DMP1-RFPmCherry increased up to day 21, suggesting successful
differentiation of BMSCs along the osteogenic lineage for both scaffolds. Notably, there was a
large jump in reporter presence from day 7 to 14 for both reporters. From raw fluorescence
data (Figure 4.3) the largest increase in reporter expression was observed from day 7 to 14,
which corroborates the intensity-adjusted data.

Figure 4.3: Raw fluorescence of BSP-GFPtopaz (A) and DMP1-RFPmCherry (B) in transgenic
BMSCs seeded atop MZ (a-d) and Healos (e-h) scaffolds at days 3 (a,e), 7 (b,f), 14 (c,g), and 21
(d,h) of osteogenic culture.
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Concomitantly, the osteogenic capability of dual-reporter BMSCs was assessed by a 2D
culture of BMSCs, and verified by the increased expression of DMP1-RFPmCherry at day 21
with corresponding phosphate mineral deposition (Figure 4.4A). BMSC chondrogenic ability
was assessed alongside osteogenic culture by undergoing pellet culture for 21 days, followed
by staining with safranin o-fast green (4.4B).

Figure 4.4: (A) Evaluation of BMSC osteogenic ability. Intensity-normalized fluorescence
images of BSP-GFPtopaz and DMP1-RFPmCherry reporters for BMSCs cultured in DMEM
(basal media), a-MEM, and osteogenic media (OG, a-MEM supplemented with ascorbic acid
and b-glycerophosphate) at day 21 of culture. Corresponding von Kossa staining of wells is
also provided. (B) Evaluation of BMSC chondrogenic ability. (B) Safranin O-fast green staining
of a 5 µm-thick section of a BMSC pellet culture at day 21.
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4.3.1.2 FACS analysis
To quantify the percentage of cells expressing a particular reporter gene, BMSCs were
harvested at days 7, 14, and 21 and subject to FACS analysis (Figure 4.2C and 2D). Data is
expressed both in terms of day (Figure 4.2C) and scaffold type (Figure 4.2D), facilitating
comparison between scaffolds and time points, respectively. Percentage of GFP, RFP, or
GFP+RFP positive cells were quantified from the overall population of fluorescent cells. At day
7, the majority of fluorescence was attributed to GFP positive cells, with smaller populations of
GFP+RFP cells, and negligible RFP-only fluorescence. At this time point, MZ scaffolds had
slightly lower GFP (73.2%) and higher RFP (22.9%) fluorescent cells compared to Healos
scaffolds (80.5% and 17.6%, respectively). At day 14, a drastic shit in overall fluorescence
occurred, lowering GFP populations while increasing GFP+RFP and RFP populations. Notably,
MZ scaffolds contained nearly double (30.7%) RFP only cells compared to Healos scaffolds. At
day 21, an overall shift toward increased RFP only fluorescence was evident, where Healos
scaffolds hosted more RFP only cells (57.1%) compared to MZ scaffolds (44.8%). Despite this
difference, both scaffolds experienced similar temporal reporter behavior, with an initial peak in
GFP only cells, followed by a sharp decline at day 14 that persists to day 21. The RFP only
population continually increases to a maximum at day 21, while GFP+RFP populations peak at
day 14 and decline at day 21.

4.3.1.3 qRT-PCR
At days 7 and 21 of osteogenic culture, mRNA was isolated and subject to qRT-PCR (Figure
4.5A) for quantification of osteogenic gene markers (Table 4.1). To assay zone-specific gene
expression, MZ scaffold zones (superficial zone – SZ, transition and calcified cartilage zones TZ/CZ, osseous zone – OZ) were carefully sectioned for subsequent mRNA extraction. At day
7, ALP, BSP, DMP-1, and OCN were upregulated in all scaffold zones, while RUNX2
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expression was upregulated in just the TZ/CZ and OZ. On the other hand, only BSP, DMP-1,
and OCN were upregulated for Healos. Notably, BSP and OCN were significantly more
upregulated for MZ scaffold zones compared to the other genes. Among scaffolds zones at
day 7, expression of ALP and OCN was significantly greater in the TZ/CZ and OZ than in the
SZ. DMP-1 expression was significantly greater in the TZ/CZ compared to that in the SZ, while
no significant increase in BSP expression was evident among scaffold zones. Healos was
found to have significantly decreased expression of all markers compared to those in at least
one zone at day 7.

At day 21, expression of ALP, BSP, DMP-1, and OCN were upregulated for all scaffold zones,
while just BSP, DMP-1, and OCN were upregulated for Healos. Interestingly, expression of all
markers significantly decreased from day 7 to day 21 in TZ/CZ and OZ zones, while expression
of only RUNX2 and OCN decreased for Healos. At day 21, while no significant differences in
gene expression between zones was found, expression of ALP was significantly higher in all
scaffold zones compared to that in Healos. Additionally, BSP expression in just the TZ/CZ was
significantly greater than that in Healos. Cycle threshold (Ct) values are provided in Figure 4.5B,
and give insight into the amount of the target gene used for fold-change quantification. A
significant quantity of genes was measured, with a Ct range between 19.28-28.21.
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Figure 4.5: (A) Quantification of osteogenic gene expression for MZ scaffold zones via qRTPCR. Fold change was expressed relative to day 2 mRNA, normalized to GAPDH expression,
and calculated via the 2-∆∆CT method. Statistical difference (p < 0.05) among scaffolds at a
given day is represented by * and calculated by one-way ANOVA. Statistical difference for a
given material from day 7 to day 21 is represented by # and was calculated by a student’s ttest. (B) Threshold cycle (Ct) values attained for chosen transcripts at days 7 and 21.

4.3.1.4 Cryohistology
To assess matrix mineralization after osteogenic culture, MZ and Healos scaffold sections were
subject to Vector Blue and von Kossa stains to assess ALP and phosphate mineral deposition,
respectively (Figure 4.6). Both MZ and Healos scaffolds stained positively for ALP and
phosphate mineral, though the SZ of MZ scaffolds displayed significantly less ALP than all
other zones. For all scaffolds, ALP deposition surrounded GFP and RFP signal. von Kossa
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staining was even across all scaffold zones, and embedded with GFP+RFP BMSCs. A small
quantity of RFP only cells was present, highlighted by the white arrows in the CCZ. Altogether,
these data evince comparable matrix mineralization of BMSCs on MZ scaffolds to Healos.

Figure 4.6: Vector Blue (ALP, upper panel) and von Kossa (VK, lower panel) staining of MZ and
Healos scaffolds at day 21 of osteogenic culture. Stained MZ scaffold sections are presented
alongside higher magnification images of the SZ, TZ, CCZ, and OZ. Dotted squares indicate
selected zonal regions. For each zone, the specified stain and Hoechst (H) are overlaid, with
either GFP, RFP, or both (Merge). White arrows in VK staining of the CCZ indicate an RFP-only
cell. Corresponding images of the Healos positive control scaffold are presented on the right.

4.3.2 Chondrocyte chondrogenesis
4.3.2.1 In situ fluorescence microscopy
Triple transgenic articular chondrocytes harboring the reporter combination Col3.6-GFPtopaz x
Col2a1-GFPcyan x Col10a1-RFPmCherry were cultured on MZ scaffolds for 21 days in defined
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chondrogenic media to evaluate the chondrogenic ability of the materials. In parallel,
chondrocytes were also cultured on IC and ICH scaffolds as controls to evaluate the influence
of material composition and anisotropy, and anisotropy alone, respectively, on chondrogenic
differentiation.
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Figure 4.7: Intensity-normalized fluorescence of Col3.6-GFPtopaz (A), Col2a1-GFPcyan (B),
and Col10a1-RFPmCherry (C) reporter expression over 21 days of chondrogenic culture on MZ
(a-d), ICH (e-h), and IC (i-l) scaffolds. Dotted squares highlight higher-magnification regions
shown in corner insets. White arrows indicate flattened cells. FACS analysis for chondrocyte
chondrogenesis (D and E) on MZ, ICH, and IC scaffolds. Positive fluorescent percentage for
specified fluorescence (GFP, CFP, RFP, GFP+CFP, CFP+RFP) from overall fluorescent cells
are shown. Data are represented in terms of day (D) and scaffold (E).

Intensity-normalized fluorescence data for Col3.6-GFPtopaz (Figure 4.7A) revealed reporter
fluorescence for all scaffolds at D3, but most widespread fluorescence over ICH scaffolds (e).
Col3.6-GFPtopaz reporter presence continually declined over the 21 days for all scaffolds, but
uniquely vanished for MZ at day 21 (d). Cell morphology varied among scaffold zones, with
cells atop the SZ (Figure 4.7A, b inset) and along the osseous lamellae (Figure 4.7A, d)
exhibiting a flattened morphology, while IC scaffolds fostered the greatest amount of flattened
cells (Figure 4.7A, k). Raw fluorescence data for the reporter (Figure 4.8A) revealed no visible
reporter presence at 300 ms exposure time, suggesting minimal reporter intensity that did not
increase over culture for all scaffolds.

Unlike Col3.6-GFPtopaz fluorescence, Col2a1-GFPcyan fluorescence remained active for all
scaffold types throughout the culture duration (Figure 4.7B). Similar to Col3.6-GFPtopaz
fluorescence, Col2a1GFPcyan fluorescence revealed zonal differences in cell morphology,
where cells were flattened atop the SZ (Figure 4.7B, b inset) and along osseous lamellae
(Figure 4.7B, d). Chondrocytes in the TZ (Figure 4.7B, a and d insets) displayed a similar
morphology to those on ICH scaffolds (Fig 4.7B, e-h insets), retaining native spherical
conformation and forming aggregates with additional chondrocytes. Chondrocytes were
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mostly flattened on IC scaffolds at all time points (Figure 4.7B, i-l insets). Further, raw
fluorescence data (Figure 4.8B) showed that Col2a1-GFPcyan signal was stable for all
scaffolds during culture.
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Figure 4.8: Raw fluorescence of Col3.6-GFPtopaz (A), Col2a1-GFPcyan (B), and Col10a1RFPmCherry (C) reporter expression over 21 days of chondrogenic culture on MZ (A-D), ICH
(E-H), and IC (I-L) scaffolds.

Uniquely, Col10a1-RFPmCherry was absent at day 3 (Figure 4.7C), but became active in all
scaffolds at D7, where it was most widespread on MZ scaffolds (b). Col10a1-RFPmCherry
presence steadily increased up to day 21 for all scaffolds, becoming most dense in osseous
zone of MZ scaffolds (d) and edges of ICH scaffolds (h). For all scaffolds, this signal appeared
highly spherical. At a constant exposure time of 300 ms (Figure 4.8C), Col10a1-RFPmCherry
activity first became apparent at day 14 for all scaffolds (c, g, k), where it was noticeably more
intense for MZ and ICH scaffolds then IC. At day 21, both reporter presence increased for all
scaffolds (g, h, l) but was significantly more intense for MZ and ICH scaffolds compared to IC
scaffolds. Though Col10a1-RFPmCherry fluorescence was overexposed for both MZ and ICH
scaffolds, there was a greater area of overexposed reporter activity (mostly localized to the
osseous zone) for MZ scaffolds. Moreover, the chondrogenic capability of triple-reporter
chondrocytes was verified in pellet culture, where all three reporters were active at day 21
(Figure 4.9).
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Figure 4.9: Confirmation of chondrocyte chondrogenesis from pellet culture at day 21. Brightfield, and fluorescence images of the pellet for Col2a1-GFPcyan, Col3.6-GFPtopaz, and
Col10a1-RFPmCherry are provided.

4.3.2.2 FACS analysis
Transgenic chondrocytes harvested at day 7 from MZ, ICH, and IC scaffolds (Figure 4.7D) were
nearly equally CFP positive (82% average), with small double-positive populations (averages of
9.4% and 8.5% for GFP+CFP and CFP+RFP populations, respectively). At Day 14,
chondrocytes from MZ scaffolds dramatically decreased in CFP fluorescence (79.2% to 45%)
with a significant increase in the in CFP+RFP population (10.9% to 53%). This same trend
persisted for chondrocytes pooled from ICH and IC scaffolds, though the decrease in the CFP
(79.4% and 71.4%) and CFP+RFP (17.2% and 24.8%) populations were less dramatic.
Chondrocytes from MZ scaffolds at day 21 rebounded in the CFP population to 65.1%, while
decreased in the CFP+RFP population (27.7%). Chondrocytes from ICH and IC scaffolds at
this time point did not notably change in fluorescent population percentages. Overall, all
scaffolds trended towards decreasing cyan fluorescence in favor of increasing CFP+RFP
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fluorescence, with negligible RFP positive cells and minimal GFP positive cells, with MZ
scaffolds fostering the greatest GFP+RFP population at day 21 (27.7%).

4.3.2.3 qRT-PCR
Genetic markers for differentiation along the fibrocartilage (COL1A1), articular cartilage
(COL2A1, AGG, and SOX9), and hypertrophic cartilage (COL10A1) lineages were analyzed at
days 7 and 21 for SZ, TZ/CZ, and OZ scaffold zones and IC and ICH scaffolds (Figure 4.10). At
day 7, all markers but SOX9 were upregulated for all materials. No significant difference among
scaffold zones was found for COL1A, COL2A1, AGG, and SOX9 at day 7. However, expression
of COL10A1 was significantly greater in the OZ compared to that in the SZ and TZ/CZ.
Expression of hypertrophic marker COL10A1 was also significantly greater in the CZ/TZ and
OZ than in IC, and IC and ICH scaffolds, respectively. Further, articular markers COL2A1 and
AGG were significantly higher in ICH scaffolds compared to the SZ at day 7.

At day 21, COL2A1, COL10A1, and AGG were upregulated for all materials, while SOX9
remained stagnant. COL1A1 was uniquely upregulated in the OZ and IC scaffolds only.
Expression of fibrocartilage marker COL1A1 had significantly declined from day 7 in the SZ,
TZ/CZ and IC scaffolds, where expression was greater in the OZ compared to that in the SZ at
day 21. COL2A1 had remained upregulated for all materials except for the TZ/CZ, where it
significantly declined. AGG and SOX9 remained upregulated for most scaffolds, though AGG
expression increased in the OZ. Most notably, COL10A1 expression had dramatically
increased for all scaffolds by day 21. Expression was greatest in the OZ (reaching a nearly
1000-fold change by day 21) compared to all other scaffolds, and expression in the TZ/CZ was
greater than that in IC and ICH scaffolds. Fold changes were determined from a significant
amount of target gene, with Ct values between 15.06 – 26.05 (Figure 4.10B).
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Figure 4.10: (A) Quantification of chondrogenic gene expression for MZ scaffold zones and ICH
and IC scaffolds via qRT- PCR. Fold change was expressed relative to day 0 mRNA,
normalized to GAPDH expression, and calculated via the 2-∆∆CT method. Statistical difference
(p < 0.05) among scaffolds at a given day is represented by * and calculated by one-way
ANOVA. Statistical difference for a given material from day 7 to day 21 is represented by # and
was calculated by a student’s t-test. (B) Threshold cycle (Ct) values attained for chosen
transcripts at days 7 and 21.

4.3.2.4 Cryohistology
To assess the character of tissue that was deposited over chondrogenic culture, MZ (Figure
4.11), IC (Figure 4.12A), and ICH scaffolds (Figure 4.12B) were cryosectioned at days 7 and 21
and subject to hematoxylin and eosin, safranin o-fast green, Vector Blue, and von Kossa
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staining. For MZ scaffolds, zonal tissue quality was analyzed. Hematoxylin and eosin staining
showed a significant increase in both cellularity and matrix in all zones, with new tissue aligned
in the direction of respective zone. In the SZ, minimal cell infiltration was observed in the thin
superficial zone, though dense, aligned matrix was present just atop. In the TZ, condensed
cellular aggregates were present at day 7, where they became more dispersed and embedded
in a network of randomly-organized, interconnected matrix at day 21. In the CCZ and OZ, the
large pore spaces facilitated chondrocyte aggregation at day 7, which then proliferated into
large aggregates by day 21. Safranin o-fast green staining showed an increase in sulfated
glycosaminoglycan deposition from day 7 to day 21 for all zones. At day 7, safranin o staining
was present in cellular aggregates in the TZ, CCZ, and OZ. At day 21, safranin o staining was
punctate in SZ and TZ, while it was denser and most abundant in the large cellular aggregates
in the CCZ and OZ. For all zones, this stain coincided with cells embedded in lacunae.
Moreover, the intensity of safranin o was consistent among the scaffold zones. Lastly, all
scaffold zones stained negative for ALP and phosphate mineral at both time points.
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Figure 4.11. Histological staining of MZ scaffold zones (SZ, TZ, CCZ, OZ) at days 7 and 21 of
chondrogenic culture. Hematoxylin and eosin (H&E), safranin o-fast green, Vector Blue (ALP),
and von Kossa stains were performed.

IC and ICH scaffolds (Figure 4.12A and B, respectively) were subject to the same four stains.
Hematoxylin and eosin showed an increase in cell number from day 7 to day 21 for both
scaffolds, while IC scaffolds were filled with an interconnected network of matrix by day 21. In
contrast, nuclei on ICH scaffolds were not joined by matrix. Lacunae were only observed on
ICH scaffolds at day 21. Safranin O staining was sparse for both scaffolds at day 7, and only
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increased on IC scaffolds. Notably, Vector Blue revealed pockets of ALP deposition on IC
scaffolds, which preceded a lightly-mineralized matrix by day 21 (von Kossa). ICH scaffolds
were negative for these stains at both time points.

Figure 4.12: Histological staining of IC and ICH scaffolds at days 7 and 21 with hematoxylin
and eosin (H&E), safranin O-fast green, Vector Blue, and von Kossa.
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4.3.2.5 Immunohistochemistry
Zonal deposition of type 1 collagen, type 2 collagen, type 10 collagen, and Indian hedgehog
homolog (Ihh) at day 21 of chondrocyte culture was analyzed by immunofluorescence imaging.
In addition, nuclei (Hoechst) and chondrocyte reporter fluorescence (Col2a1-GFPcyan and
Col10a1-RFPmCherry) was captured and overlaid with the immunofluorescence signal. Signal
for Col3.6-GFPtopaz was scanned, where no signal was present across the entire scaffold
(Figure 4.13).

Figure 4.13: Intensity-normalized Col3.6-GFPtopaz reporter activity of articular chondrocytes at
day 21 for MZ, IC, and ICH scaffolds.
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Type 1 collagen (Figure 4.14A) was present in all scaffold zones, but was most intense in the
SZ compared to the TZ, CCZ, and OZ. Though minimal matrix infiltrated the compressed pores
of the SZ, most accumulated on the surface and was laterally aligned. Col2a1-GFPcyan
positive chondrocytes were mostly embedded inside this matrix, where Col10a1-RFPmCherry
activity was co-expressed in hypertrophic cells. Type 1 collagen immunofluorescence
diminished in the TZ, CZ, and OZ. In cellular aggregates in the CCZ and OZ, type 1 collagen
matrix was heterogeneously deposited.

Type 2 collagen (Figure 4.14B) filled the pore volume of all zones, where it was most prominent
in the SZ, CCZ, and OZ. Once again, minimal matrix infiltrated the small pores of the SZ, while
an abundance was aligned atop them and embedded with mostly Col2a1-GFPcyan positive
chondrocytes. This same matrix composition was evenly deposited in the pores of the TZ. In
the CCZ and OZ, aggregates of articular and hypertrophic chondrocytes were surrounded by a
rich layer of type 2 collagen and embedded in a matrix abundant in sulfated
glycosaminoglycans, as judged from the safranin o overlay.
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Figure 4.14: Immunofluorescence for zonal deposition of type 1 collagen (A) and type 2
collagen (B). Hoechst and Col2a1-GFPcyan and Col10a1-RFPmcherry reporter fluorescence is
overlaid atop the immunofluorescence and shown with Hoechst, Col2a1-GFPcyan, Col10a1RFPmCherry, and Col2a1-GFPcyan+Col10a1-RFPmCherry. In B, type 2 collagen
immunofluorescence, Col2a1-GFPcyan, and Col10a1-RFPmCherry fluorescence are overlaid
atop a safranin o-fast green counterstain on the same section. Color of text corresponds to
color of signal in images.

Hypertrophic markers type 10 collagen and Ihh were also assayed for in each zone (Figure
4.15A and B, respectively). Both proteins were evident in all zone, though at different
intensities. Type 10 collagen matrix was strongest in the OZ, where it encapsulated aggregates
of Col2a1-GFPcyan and Co10a1-RFPmcherry positive cells. Ihh was most prominent in cellular
aggregates of the CCZ and OZ, where the greatest amount of Col10a1-RFPmCherry signal
was also present. Ihh was localized with all Col2a1-GFPcyan and Col10a1-RFPmCherry
fluorescence.

88

Figure 4.15: Immunofluorescence for zonal deposition of type 10 collagen (A) and indian
hedgehog homolog (Ihh, B) in MZ scaffolds. Hoechst and Col2a1-GFPcyan and Col10a1RFPmCherry reporter fluorescence is overlaid atop the immunofluorescence and shown with
Hoechst, Col2a1-GFPcyan, Col10a1-RFPmCherry, and Col2a1-GFPcyan+Col10a1RFPmCherry. Color of text corresponds to color of signal in images.

In both IC (Figure 4.16A) and ICH (Figure 4.16B) scaffolds, deposited matrix was also a
composite of types 1, 2, and 10 collagens and Ihh. Matrix infiltrated the pores and adopted the
templated pore architecture. Uniquely, an abundance of Col3.6-GFPtopaz fluorescence was
observed on IC scaffolds only (Figure 4.13), while none was observed on ICH scaffolds. On
both scaffolds, Col2a1-GFPcyan was most abundant, with few co-localized Col10a1RFPmChery fluorescence. The amount Col10a1-RFP-mCherry fluorescence was diminished
compared to the CCZ and OZ of MZ scaffolds. Moreover, while type 1 collagen was
significantly detected on IC scaffolds, minimal was present in ICH scaffolds. Importantly, Ihh
fluorescence co-localized with all signals for both scaffolds.
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Figure 4.16: Immunofluorescence for type 1 collagen, type 2 collagen, type 10 collagen, and
Indian hedgehog homolog for IC (A) and ICH (B) scaffolds. Hoechst and Col2a1-GFPcyan and
Col10a1-RFPmcherry reporter fluorescence is overlaid atop the immunofluorescence (IF) and
shown with Hoechst, Col2a1-GFPcyan, Col10a1-RFPmCherry, and Col2a1GFPcyan+Col10a1-RFPmCherry. Color of text corresponds to color of signal in images.

4.3.2.6 Subcutaneous implantation
Finally, we sought to evaluate the fate of chondrocyte-seeded constructs in a vascularized
environment in vivo. MZ scaffolds were cultured for 1 week in defined chondrogenic medium
then implanted in subcutaneous pockets of NSG mice for 8 weeks. Harvested tissue was
subject to safranin o-fast green, Vector Blue, and von Kossa stains, where reporter
fluorescence was superimposed (Figure 4.17). After 8 weeks, the scaffolds had been
encapsulated in a fibrous tissue and infiltrated with a fibrous-like tissue. Pockets of cellular
aggregates rich in sulfated proteoglycan were present, and were comprised of cells harboring
Col3.6-GFPtopaz, Col2a1-GFPcyan, and Col10a1-RFPmcherry reporters. Notably, some
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Col10a1-RFPmCherry fluorescence became independent of the other reporters in these
aggregates.

Unlike the in vitro culture, harvested scaffolds stained positively for both ALP and phosphate
mineral. Both ALP and mineral nodules consisted of Col10a1-RFPmCherry fluorescence
surrounded by Col3.6-GFPtopaz and Col2a1-GFPcyan fluorescence. Unseeded MZ scaffolds
similarly pre-cultured in defined chondrogenic media for 1 week and implanted alongside the
seeded scaffolds displayed significant host cell infiltration and fibrous tissue infill, but lacked
safranin o, ALP, or mineral staining, indicating donor cells were required for proteoglycan and
mineral formation.
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Figure 4.17: Histological staining of chondrocyte seeded (A) and unseeded (B) MZ scaffolds
implanted subcutaneously in NSG mice for 8 weeks. Scaffolds were subject to a 1-week preculture in defined chondrogenic media prior to implantation. Tissues were stained with safranin
O-fast green (SO-FG), Vector Blue (ALP), and von Kossa (VK). In A, Whole MZ scaffold sections
subject to the indicated stain are first shown, followed by higher magnification images of a
selected area (denoted by boxed lines in the whole MZ scaffold section). Stains are overlaid
with Hoechst (H), Col3.s6-GFPtopaz (GFP), Col2a1-GFPcyan (CFP), Col10a1-RFPmCherry
(RFP), and CFP+RFP fluorescence. White arrows highlight RFP-only cells. In B, whole MZ
scaffold stains are shown alongside the stain with Hoechst.
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4.4 Discussion
In vitro cellular differentiation on biomaterials is conventionally assessed by destructive
characterization modes, including gene expression analyses and histological staining. Such
methods are not only destructive, but fail to provide spatiotemporal information of cellular
maturity along a specific lineage. To overcome these limitations, we turn to the use of
fluorescent multi-reporter cells that provide real-time readouts of cellular identity.

The Rowe laboratory has generated various lines of transgenic mice harboring GFP reporters
to study bone and cartilage biology and pathology. To date, only one study has been published
that describes the use of transgenic reporters to assess cellular differentiation on biomaterials;
the COL1A1 2.3 kb fragment-driven GFP reporter was used as a readout of osteoblastic
differentiation of murine BMSCs on carbonated hydroxyapatite. However, this reporter
becomes active during late-stage osteoblast mineralization, failing to reveal early commitment
to the osteoblastic lineage or differentiation to other lineages.[145]

As a first step to evaluating the regenerative potential of our MZ scaffolds, we have chosen to
separately study osteogenesis and chondrogenesis of transgenic murine BMSCs and
chondrocytes, respectively, by primarily monitoring the fluorescence of multiple transgenic
reporters. For osteogenesis, BMSCs from mice containing both BSP-GFPtopaz and DMP1RFPmCherry reporters were harvested. BSP, a non-collagenous matrix protein that nucleates
hydroxyapatite growth, is expressed in early-differentiated osteoblasts,[146] while DMP-1 is an
osteocyte-specific phosphoprotein present in mineralized mouse, rat, and chicken
tissues.[147,148] For successful osteoblastic differentiation, we expect to see a transition from
BSP-GFPtopaz to DMP1-RFPmCherry fluorescence. The combination of these BSP and DMP-
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1- promoter driven GFPs therefore permits the progressive evaluation of maturity along the
osteoblast lineage.

For chondrogenesis, we chose the triple reporter combination of Col3.6-GFPtopaz x Col2a1GFPcyan x Col10a1-RFPmCherry to provide readouts of multi-lineage chondrocyte
progression. The Col3.6-GFPtopaz transgene contains a 3.6 kb DNA fragment of the COL1A1
promoter that activates at basal levels in preosteoblasts and intensifies during osteoblastic
differentiation. It has also been shown to activate during differentiation into tendon, skin, and
lung tissues. It was also active in dermal fibroblasts and has been used to label
fibrochondrocytes in the murine temporomandibular joint.[138,140,141,149] The Col2a1-GFPcyan
transgene activates CFP upon Col2a1 promoter activation and has been shown to be
expressed in articular cartilage.[140,149,150] Lastly, the Col10a1-RFPmCherry transgene produces
an RFP upon Col10a1 promoter activation and has been used to label hypertrophic
chondrocytes in the temporomandibular joint.[141,149] For chondrogenic differentiation, we would
expect decreasing Col3.6-GFPtopaz fluorescence as chondrocyte dedifferentiation diminishes,
alongside a transition from Col2a1-GFPcyan to Col10a1-RFPmCherry as chondrocytes mature.
Hence, this multi-reporter system is suited for validating the chondrocyte phenotype on our MZ
scaffolds under chondrogenic conditions.

Guided primarily by the use of these reporters, we have concluded the following about our MZ
scaffolds: (1) MZ scaffolds were able to support the differentiation of both BMSCs and
chondroctyes in vitro, and (2) subtle differences in zone-specific cellular phenotype and tissue
were identified.
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Indeed, MZ scaffolds promoted the differentiation of BMSCs to a degree similar to Healos, as
evidenced at the reporter (continued progression from BSP-GFPtopaz to DMP1-RFPmCherry
fluorescence, Figure 4.2), genetic (upregulation of BSP and DMP-1, Figure 4.5), and protein
(zonal deposition of ALP and phosphate mineral, Figure 4.6) levels. As expected, the chondral
layers (SZ, TZ, and CCZ) did not outright prohibit osteogenic differentiation. However, zones
containing hydroxyapatite demonstrated the greatest osteogenic ability, as judged by the
enhanced expression of ALP, BSP, DMP-1, RUNX2, and OCN relative to other scaffold zones
and Healos (Figure 4.5). This effect is presumably influenced by PO43- ion release and
subsequent A2b adenosine receptor activation.[86] Importantly, the use of the reporters was
able to uniquely identify the phenotype of seeded BMSCs unlike gene expression or
histological analyses. At the end of culture, roughly half (44.8% for MZ and 57.1% for Healos)
of fluorescent cells had progressed to sole DMP1-RFPmCherry fluorescence, with a depletion
in BSP-GFPtopaz and double-positive fluorescent populations. This observation clearly
indicates that BMSCs had continually matured to osteocytes throughout the culture period. At
the protein level, DMP-1 is processed into C-terminal and N-terminal fragments, where the
former mediates osteocyte maturation and mineralization, whereas the former controls
phosphate homeostasis.[151] The presence of robust ALP deposition and heavily mineralized
matrices at day 21 corroborates this conclusion of osteocyte maturation.

Like BMSCs, MZ scaffolds supported the maturation of triple-reporter articular chondrocytes
to a hypertrophic-like phenotype over the 21-day culture period, as judged by increased
activity and fluorescence of the Col10a1-RFPmCherry reporter (Figures 4.7C and 4.8C),
marked increased in COL10A1 expression (Figure 4.10A), and presence of type 10 collagen
matrix with CFP+RFP positive cells embedded within (Figure 4.15A). Importantly, this
progression to hypertrophy was not unique to our MZ scaffolds, but also present on IC and
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ICH scaffolds, as well as the pellet culture. These data indicate that hypertrophic induction is a
function of the culture conditions rather than the chosen substrate. Under standard
chondrogenic conditioning with TGF-b, MSCs express hypertrophic markers, such as type 10
collagen, ALP, and MMP13.[152,153] Furthermore, the presence of TGF-b1 and dexamethasone
may not totally prohibit terminal differentiation, but slow its progression.[152,153] In our
experiments, we did not see histological deposition of ALP, or matrix mineralization (Figure
4.11), which is a unique phenotype reminiscent of costal cartilage chondrocytes.[152,154] In costal
cartilage chondrocytes prior to puberty, type 10 collagen is solely expressed, where ALP
activates during puberty and initiates matrix mineralization. Mineralization will not occur without
the presence of additional signaling proteins, such as exogenous insulin-like growth factor or
the c-terminus fragment of parathyroid hormone; despite the expression of type 10 collagen,
costal cartilage is still of hyaline character.[155] Therefore, we believe that some of our cultured
chondrocytes (27.7% of reporter cells, Fig 5E) have reached a pre-hypertrophic stage of
maturity, but not terminal maturation. These chondrocytes are stable at day 21 and still retain
an articular-like phenotype, as judged by continued upregulation of COL2A1 (Figure 4.10A) and
significant deposition of type 2 collagen matrix throughout the scaffold (Figure 4.14B). Further
in support of this conclusion is the finding that the majority (> 65%) of total fluorescent
chondrocytes were solely Col2a1-GFPcyan positive for all scaffolds. There was a negligible
percentage of cells found to be solely Col10a1-RFPmCherry positive, indicating that terminal
maturation was not achieved. These data highlight that our MZ scaffolds may be of clinical
relevance to support an articular-like phenotype during in vitro culture.

To pin-down the phenotype of the Col2a1-GFPcyan+Col10a1-RFPmCherry cells at the end of
the culture period, we performed immunohistochemistry for Ihh, an indicator of prehypertrophic
chondrocytes. Indeed, we saw wide-spread Ihh localized to the cytoplasm of day 21
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chondrocytes. In prehypertrophic chondrocytes, Ihh inhibits the onset of endochondral
ossification by activating endogenous parathyroid hormone-related protein expression, which
in turn suppresses Ihh activity in a negative-feedback loop.[153] In fact, it has been shown that
TGF-b’s function to suppress hypertrophy is mediated through endogenous Ihh activity; TGF-b
signaling induces phosphorylation of SMAD2/3, which binds to SMAD4, then induces Ihh
transcription. Paracrine/autocrine Ihh signals subsequently induce SOX9 expression.
Concomitantly, endogenous TGF-b3 and BMP-2 activity are induced by TGF-b1, which cause
further SMAD2/3 phosphorylation, Ihh transcription, SOX9 expression, inducing Col10a1
expression.[153] Thus, it is likely that TGFb1 may be acting to maintain the pre-hypertrophic
phenotype through Ihh signaling.

Our next step was to study the stability of our chondrocyte-seeded MZ scaffolds in a
vascularized environment in vivo, with particular interest in studying the fate of the prehypertrophic chondrocyte population. With this in mind, chondrocyte-seeded MZ scaffolds
were cultured in chondrogenic media for one week prior to subcutaneous implantation to
establish an initial pre-hypertrophic chondrocyte population (Figure 4.7C, b). Upon exposure to
a vascularized environment, we had hypothesized that pre-hypertrophic chondrocytes would
follow an endochondral ossification regime upon exposure to signaling molecules such as
insulin-like growth factor and parathyroid hormone present in the vasculature. Indeed, after 8
weeks of implantation, MZ tissues stained positively for ALP and phosphate mineral (Figure
4.17). A telling sign of terminal maturation of implanted chondrocytes was observation of
exclusive Col10a1-RFPmCherry fluorescence, present in the center of cellular aggregates
(Figure 4.17, white arrows). The presence of significant Col3.6-GFPtopaz reporter activity
localizing with mineralized nodules and ALP deposits may be indicative of osteoblastic
differentiation, as it is unlikely for fibrochondrocytes to localize with osseous structures. This
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subcutaneous implantation follows an endochondral ossification-like process, where
chondroprogenitors aggregate, differentiate into hypertrophic chondrocytes, and mineralize to
provide a template for bone formation.[12,154] Further, the subcutaneous environment has been
validated as a suitable model for studying endochondral ossification.[156,157] It is our
understanding that the presence of TGFb and dexamethasone in the defined chondrogenic
media merely suppress the natural tendency of chondrocytes to reach terminal maturation
during culture; the removal of these factors combined with the presentation of prohypertrophic signaling molecules in the vasculature promote continued chondrocyte
maturation. This presents an important implication when considering the supposed stability of
articular chondrocytes for clinical treatment of articular cartilage defects, as is discussed later.

Our second conclusion from the study was that zonal scaffold properties lead to subtle
differences cellular phenotype and tissue. Chondrogenic culture of triple-reporter chondrocytes
led to the formation of a composite matrix of type 1, type 2, and type 10 collagen in all
scaffolds, regardless of zonal matrix orientation or composition (Figures 4.14-4.16). The
composite tissue that was formed may be a result of a heterogeneous differentiation regime,
where a small portion (<12%, Fig 4.7D) of the cultured chondrocytes produced type 1 collagen
from de-differentiation into a fibrocartilaginous phenotype. It is our understanding that the
major components of the produced matrix are types 2 and type 10 collagens, produced from
the majority of chondrocytes that were either only Col2a1-GFPcyan or Col2a1GFPcyan+Col10a1-RFPmCherry positive. These data highlight that soluble factors present in
the differentiation media are the most critical mediators for cellular phenotype and tissue
formation. It will be important in future studies to quantify the amount of protein deposited in
each zone to further distinguish zonal tissue composition.
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Despite the lack of obvious differences in cellular phenotype or matrix composition, there were
significant differences in the extent of gene or protein production in each zone. At the both the
fluorescence and RNA level, Col10a1 was maximal in the OZ compared to other scaffold zones
or reference IC and ICH scaffolds. The OZ deliberately contains the most hydroxyapatite (25
wt%) in the scaffold.[136] Hydroxyapatite has been found to promote expression of type 10
collagen of chondrocytes and MSCs in a dose-dependent manner, though the mechanism for
which is unclear and mandates mechanistic understanding.[84,158,159]

Intensity of safranin-o staining also varied with zone and was greatest in the CCZ and OZ
compared to the SZ and TZ. The large pore areas within the CCZ and OZ supported the
formation of large cellular aggregates rich in sulfated glycosaminoglycans. These aggregates
are indicative of chondrogenesis, where cell-cell interactions are favored that stabilize the
chondrogenic phenotype and follows embryological chondrogenesis from MSCs.[12] Though
aggregates were found in both the CCZ and OZ, they were larger and more spherical in the
CCZ, surrounded directly by type 1 collagen-hyaluronic acid scaffold matrix. The negatively
charged carboxyl groups of hyaluronic promote a spherical morphology of seeded
chondrocytes, which may facilitate aggregation of chondrocytes in the spherical aggregate
shown.[53,81] In contrast, aggregates in the OZ are elongated with the direction of the
mineralized collagen scaffold lamellae, where cell-matrix interactions are favored in the
absence of hyaluronic acid. All aggregates were co-localized with abundant Col10a1RFPmCherry signal (Figures 4.11, 4.14, 4.15), indicating that these aggregates were
undergoing hypertrophic differentiation. The high proteoglycan content may serve as binding
sites for hydroxyapatite nucleation, ultimately leading to mineralization as observed in the in
vivo data.[160]
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Lastly, direction of neo-tissue was templated by the scaffold pores, as shown in
immunohistochemical data (Figures 4.14 and 4.15), and formed zone-specific alignment. The
ability of the tissue to adapt the surrounding pore morphology is a powerful tool to ensure the
reconstruction of new tissue that recapitulates native zonal organization. It is expected that the
composition and geometry of the pore networks facilitated the formation of an organized
collagen matrix across multiple length scales. Compositionally, the abundance of free hydroxyl
and carboxyl groups on the collagen and hyaluronic acid present in the pore network can form
hydrogen bonds with hydroxyl groups on secreted collagen monomers, templating their growth
into aligned fibrillar bundles.[161] Geometrically, the microscale confinement of the pore
networks stimulates aligned collagen fibrillogenesis.[162,163] We further speculate that the
presence of HYA can bind water molecules, enhancing molecular crowding, which drives
organized fibrillogenesis.[162] Together, these mechanisms allow for the formation of aligned
collagen fibrils and fibers, which are directionally templated by the microscale pore network.
This orientation shall remain once the scaffolding biodegrades in vivo, as we have shown in our
previous studies.[120,127]

Several limitations of the current study exist that warrant addressing. First is the discrepancy
between day 21 osteogenic gene expression data and fluorescence/histological data. As
observed in Fig 3, expression of all bone markers declined from day 7 to day 21. This is in
direct conflict with the observation that both BSP-GFPtopaz and DMP1-RFPmCherry reporters
increased in both number and intensity continually throughout culture, and the histological
finding of abundant ALP deposition. It is likely that osteogenic cells were buried under a
heavily-mineralized matrix (Figure 4.6), making RNA retrieval difficult. This points to the
limitations of qRT-PCR and the advantages of reporter fluorescent evaluation; in a nonquantitative manner, it may replace qRT-PCR analyses. Second, the SZ of the MZ scaffolds
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fostered limited cellular infiltration and subsequent matrix deposition. Instead, laterally-aligned
tissue was formed on the surface of the SZ in an area with less-compressed scaffold pores
which remains from the scaffold fabrication process. The lack of matrix formation in this zone
is most likely attributed to cell-seeding, as cells were seeded on both surfaces of the scaffold;
cell and tissue presence relies on cellular migration to the scaffold interior. Further, when
implanted in vivo, and abundance of laterally-aligned fibrous tissue was formed inside this
zone by host cells (Figure 4.17). Additional experiments will call upon an improved seeding
procedure to ensure adequate infiltration of seeded chondrocytes in this layer.

The results of this study have broad implications to the design and use of zonal scaffolds for
osteochondral tissue engineering. While we were successful at attaining zonally-organized
neo-tissue, future work will focus on achieving zone-specific tissue. Here, the ability of
chondrocytes to undergo hypertrophic differentiation may be leveraged. Zonal osteochondral
tissue may be achieved from a single population of articular chondrocytes by promoting the
tendency of chondrocytes to undergo endochondral ossification in the OZ, while prohibiting or
suppressing this tendency in upper chondral zones through the addition of various signaling
molecules When implanted in an osteochondral defect, exposure to a vascularized
subchondral environment may turn the hypertrophic osseous template into vascularized bone
via endochondral ossification, as we have seen in our in vivo data. Here, a physical barrier
must be introduced to prevent vascular invasion from ossifying tissue, which may be
introduced through modifying the modular lyophilization bonding procedure. This use of a
single cell population for zonal osteochondral tissue engineering precludes the difficulty of
finding a common cell culture medium for both BMSCs and chondrocytes, aiding clinical
translatability.[164]
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4.5 Conclusions
Altogether, the utilization of reporter cells endows us with a powerful tool to non-destructively
evaluate cellular phenotype in situ. Furthermore, these GFP activity remains stable post culture.
Using cryohistological protocols, reporter activity may be overlaid with histological or
immunochemical analysis, as evinced in this study. In our study, we have shown successful
BMSC osteogenic differentiation on our MZ scaffolds from the progressive activation of
exclusive BSP-GFPtopaz to DMP1-RFPmCherry reporters. Chondrocyte maturity was verified
by observing a continual transition from Col2a1-GFPcyan exclusivity to Col2a1GFPcyan+Col10a10-RFPmCherry fluorescence, suggesting a population of cells became prehypertrophic. This was confirmed by histological and immunohistochemical analyses. Subtle
differences in cellular phenotype and zonal tissue were identified. The combination of these
reporters with MZ scaffolds may guide their continued for the reconstruction of functional
osteochondral tissue. Moreover, a wide variety of reporter cells exist that can be used to
evaluate other biomaterial systems both in vitro an in vivo.
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Chapter 5
Conclusions and future work
5.1 Conclusions
This work has addressed the demand for a monolithic biomaterial that recapitulates the zonal
orientation and composition of native osteochondral tissue. In fulfillment of this objective, a
unidirectional freeze-casting approach was first pursued that would be the foundation for
structural anisotropy in zonal scaffolds. An optimized protocol for generating uniaxially-aligned
collagen sponges was first developed. Though a systematic investigation into structural
collapse, it was determined that the combination of both a low acetic acid concentration (0.05
M) and lyophilization temperature (-40ºC) facilitated the production of structurally-intact,
porous collagen scaffolds.

Outcomes of the prior study were applied to develop multizonal collagen scaffolds that mimic
the orientation and composition of osteochondral tissue. This was accomplished by leveraging
the unidirectional freeze casting approach in a modular fashion. Orthogonally-oriented
unidirectional scaffolds were combined with an intermediate collagen-hyaluronic acid
suspension and freeze dried. In this manner, monolithic scaffolds were generated that
contained a laterally-aligned superficial zone, isotropic transition zone, lamellar osseous zone,
and a transitionary calcified cartilage region. The modular approach allowed for zone-specific
composition based on initial slurry formulations used to construct the three scaffold areas.
These materials were extensively characterized morphologically and compositionally, being
deemed promising for the regeneration of osteochondral tissue by progenitor cells.

Multizonal osteochondral scaffolds were then characterized for their ability to promote
osteochondral differentiation of progenitor cells. Here, transgenic reporter cells were used as
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tools to track cellular differentiation in real-time during culture and provide additional
information of cellular identity in histological analyses. BMSCs were first seeded atop
multizonal scaffolds and cultured in osteogenic conditions. Reporter analysis revealed
successful conversion of early-ostoeblastic cells (BSP-GFPtopaz) to late stage
osteoblastic/early stage osteocytic cells (DMP1-RFPmCherry) by monitoring reporter
expression. Further, primary articular chondrocytes containing reporters for tri-lineage
differentiation into fibrocartilage (Col3.6-GFPtopaz), articular cartilage (Col2a1-GFPcyan), and
hypertrophic cartilage Col10a1RFP-mCherry) were separately cultured on multizonal scaffolds
in chondrogenic conditions. While the culture conditions promoted overall pre-hypertrophic
differentiation, subtle differences in zone-specific cellular phenotype and tissue were observed.
Multizonal scaffolds promoted the formation of zonally-aligned tissue. Additionally, scaffold
zones containing hydroxyapatite were found to be pro-hypertrophic. When ectopically
implanted, chondrocyte-seeded scaffolds mineralized, suggesting their tendency to ossify
when exposed to a vascularized environment.

The data gathered in this work represent significant progress in the design of zonal scaffolds
that aim to regenerate zonally-organized osteochondral tissue. These data also provide
important insight into novel research avenues to be further taken. With the future work
proposed in the following section, the clinical utility of multizonal scaffolds may be realized.

5.2 Future work
5.2.1 Zonal osteochondral tissue engineering with primary chondrocytes
As the work in the fourth chapter of this thesis has shown, the fate of articular chondrocytes is
most strongly affected by the media composition. Particularly, conditioning with TGFb permits
progression to a pre-hypertrophic phenotype in vitro. As was shown, these pre-hypertrophic
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chondrocytes are subject to ossification when implanted ectopically. This tendency may be
leveraged to generate a pre-hypertrophic template in the osseous zone and stable articular
chondrocytes in the chondral layers. Upon implantation, the hypertrophic chondrocytes in the
osseous zone may be turned over into bone, while stable articular chondrocytes may remain in
the upper layer with the application of the right morphogens to control cell fate. This vision may
be realized with the following four proposals.

5.2.1.1 Optimal morphogen selection
The reporter system used in the fourth chapter will be used to screen out optimal pro-articular
morphogens that will ultimately be conjugated to the chondral layer. Primary articular
chondrocytes containing the three reporters used in the prior study (Col3.6-GFPtopaz x
Col2a1-GFPcyan x Col10a1-RFPmCherry) will be seeded atop multizonal scaffolds in growth
medium and supplemented with a defined set of morphogens and cultured independently. The
reporters will serve as real-time readouts of cell fate to identify which morphogen allows for
exclusive Col2a1-GFPcyan activity. The effect of these morphogens on cellular phenotype will
be investigated in further details in methods similar to those employed in the fourth chapter of
the dissertation.

5.2.1.2 Optimization of the calcified cartilage layer
The modular lyophilization bonding procedure will be revisited with the goal of engineering a
semi-permeable barrier in the calcified cartilage zone. This barrier will function to separate proarticular (chondral layers) and pro-chondrogenic (osseous zone) factors while permitting the
diffusion of small molecules that promote basic cellular functions. This semi-permeable barrier
is mimetic of the role the calcified cartilage layer plays in vivo to prevent vascular invasion of
the articular cartilage. This barrier may be imparted during assembly of multidirectional
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scaffolds at the junction of the osseous zone and transition zone suspension. For example, a
semi-permeable collagen-HA barrier may be engineered to possess a pore size selectively
permissible for sub-morphogen-sized molecular diffusion. This membrane can then be placed
between osseous and transition zone suspensions and freeze-dried to bind to the bulk
construct.

5.2.1.3 Morphogen-scaffold conjugation
With an effective pro-articular morphogen screened out, this molecule will then be selectively
added to the superficial zone scaffold by incorporation into the initial collagen-suspension prior
to unidirectional freeze casting. Inclusion of the morphogen via this method allows for it to be
incorporated within the collagen, its release dependent largely on the degradation of the
scaffold. Further, pro-chondrogenic TGFb will be included in the osseous zone via the same
method. Migration of the molecules across the barrier will be assessed using fluorescent
analogs and tracking their migration via fluorescent microscopy. Further, a release study of the
molecules will be conducted.

5.2.1.4 In vivo validation of zonal osteochondral repair.
A validated small-animal model for studying osteochondral defect repair (e.g. rabbits, goats),
will be used to evaluate the ability of multidirectional scaffolds to direct zonal osteochondral
repair. Primary articular chondrocytes carrying the three reporter combination will be seeded
on morphogen-conjugated scaffolds and cultured in vitro to generate pre-hypertrophic
chondrocytes only in the osseous layer. Scaffolds will then be implanted in critical-size defects
and repair will be evaluated histologically at 3, 6, and 12 months. The use of the reporters will
allow for interpretation of host-cell contribution to tissue repair. If separate chondral and
osseous tissues were formed, it is also expected that new tissue to be zonally organized with
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the scaffold template after it biodegrades. Fulfillment of these objectives may usher in a new
and effective treatment modality for osteochondral trauma or disease.
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